Archive for the ‘Life Extension’ Category

Play like you have this decision to make: Worldwide, in developed nations, people max out on average at 80 years. If you could have your life extended 40 years beyond that, would you go for it? Simply answer yes or no, please.

Genesis 6:3 might help. My spirit will not contend with humans forever, for they are mortal, it quotes the Lord. Their days will be a hundred and twenty years. Some scientists agree that 120 is about our limit.

Some doubt there is a life limit. So, lets add a scenario: What if you could choose to live forever? You go for that?

Is either 120 or immortality even possible? Answers: yes and maybe, well see.

Its yes because Jeanne Calment of Arles, France, lived to a now verified 122 years and 164 days. Jeanne stopped smoking at 117, but never gave up her nightly port wine. She took up fencing at 80 and bicycled into her 100s. When asked on her 120th birthday what she expected from the future, she said, I expect a short one. Jeanne was born in 1875 and died in 1997.

Many scientists use Calments age as sort of a doable goal for extending life. According to Woody Allen, You can live to be 100 if you give up all the things that make you want to live to be 100. But 100 aint 120. And Woodys quip doesnt answer whether we can end The End for humans. Could other species shed light?

Some species might suggest there is no life-limit. Tortoises live to 255; an invertebrate Quahog clam clocked in at 507; Greenland shark, 512; and one bristlecone pine dubbed the Methuselah, is 4,852 years old. But according to Aging Research Reviews as reported in National Geographic, the winner is a deep-sea sponge. Age: at least 11,000 years.

So, whats up? Human age is up. This year, the United Nations expects the number of centenarians, worldwide, to exceed 573,000. For perspective, eight years ago, the United Nations estimated that there were only 316,600 living centenarians worldwide.

But beyond 100, Mother Nature hits the brakes. The number of supercentenarians, those making it into the 110 club, though not known for sure, is estimated to be about 600, worldwide.

What is known is that as of Oct. 21, there were 50 supercentenarians (18 from the U.S. and 11 from Japan; 90 percent female.) The aging curve changes between 100 and 110.

According to British actuary Benjamin Gompertzs predictions, the mortality rate for adult humans roughly doubles every additional eight years. However likely you are to die in 2020, youll be twice as likely in 2028, four times as likely in 2036. The death curve goes up like that, sharply till 100.

So, while reaching 100 is still unlikely at present, if you do reach it, things begin looking up. The sharpness of Gompertzs mortality curve flattens out at about 100.

Some scientists have explained that the deceleration of the death rate beyond 100 could suggest that there is no fixed limit to the human lifespan.

Traditionally, aging has been viewed as inevitable as death. But what if age isnt inevitable, but a curable disease? What about death then?

British gerontologist Aubrey de Grey, chief science officer at a California research foundation, says aging is not unavoidable, its simply a medical problem that science can solve. While de Grey does consider life extension a health issue eliminating age-related diseases like cancer, stroke, Alzheimers, heart disease, etc. he views it from different lenses.

Treating and beating age-associated diseases has always been approached discreetly. Tackle this, tackle that. But thats precisely because aging has never been regarded as a disease. If it were, and were conquered, then age-associated diseases would no longer exist. Win-win.

David Masci, a researcher for Pew Research Center, says life extension is no longer the realm of cranks and science fiction writers. Heavy hitters are pouring serious money into tackling aging at its root.

From 1997 to 2013, Oracle co-founder billionaire Larry Ellison contributed $45 million annually to his Ellison Medical Foundation, which focuses on the aging process while simultaneously lowering and eliminating age-related diseases.

Ellison stopped contributing in 2013 because Google founded California Life Co., which seeks to reverse-engineer the biology that controls lifespan and devise interventions that enable people to lead longer and healthier lives essentially Ellisons goal.

Life extension approaches vary, from ways to eliminate decrepit (senescent) cells, to pursuing Metformin, the closest now to a drug that appears to target aging, to extrapolating from discovery that a single-gene mutation doubles the lifespan of certain roundworms.

So maybe well see. Meanwhile, remember that Lucille Ball said, The secret of staying young is to live honestly, eat slowly, and lie about your age.

Michael Smith is a Southern Pines writer.

Follow this link:
Column: Just How Old Is 'Old Age' in The Future? - Southern Pines Pilot

Global Oral Probiotics market report 2020 offers extremely oblique professional analysis and forecast from 2020 to 2026. The report also consists of market shares, size, profit revenue, and the Oral Probiotics markets economic process. It also covers the strategic identification of major players within the market and analyzing their core competencies and methodology. The Oral Probiotics market report analyzes information collected and integrated through recent analysis techniques and from trustful sources across varied industries.

A thorough evaluation of the restrains encompassed in the Oral Probiotics report reveals the difference to drivers and contributes room for strategic planning. Features that overshadow the Oral Probiotics market development are essential. They can be understood to devise different bends for getting hold of the profitable prospects present in the ever-growing market. Additionally, perceptions by market expert opinions have been taken to understand the Oral Probiotics market better.

[Due to the pandemic, we have included a special section on the Impact of COVID 19 on the market which would mention How the Covid-19 is Affecting the Global Oral Probiotics Market]

Get a Sample Copy of this Report @https://www.futuristicreports.com/request-sample/53001

Top Key Players of Oral Probiotics Market:

(Oragenics, Life Extension, TheraBreath, Lallemand, Bluestone Pharma, Jarrow Formulas, Now Foods, BioGaia, ProBiora Health, Hyperbiotics, Bifodan)

On the basis of Types, the Oral Probiotics market:

Powder Chewable tablets Others

On the basis of Applications, the Oral Probiotics market:

Child Adult

To Understand How Covid-19 Impact Is Covered in This Report With additional Discount: https://www.futuristicreports.com/check-discount/53001

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2026) of the following regions are including,

The Research aims of the Oral Probiotics Market report would be:

Major TOC points

1Oral Probiotics Market Overview

1.1 Product Overview and Scope of Oral Probiotics

1.2 Segment by Type

1.2.1 Global Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Type 1

1.2.3 Type 2

1.3 Segment by Application

1.3.1 Sales Comparison by Application: 2020 VS 2026

1.3.2 Application 1

1.3.3 Application 2

1.4 Global Market Size Estimates and Forecasts

1.4.1 Global Revenue 2016-2026

1.4.2 Global Sales 2016-2026

1.4.3 Oral Probiotics Market Size by Region: 2020 Versus 2026

2 Global Oral Probiotics Market Competition by Manufacturers

2.1 Global Sales Market Share by Manufacturers (2016-2020)

2.2 Global Revenue Share by Manufacturers (2016-2020)

2.3 Global Average Price by Manufacturers (2016-2020)

2.4 ManufacturersOral Probiotics Manufacturing Sites, Area Served, Product Type

2.5 Market Competitive Situation and Trends

2.5.1 Oral Probiotics Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.6 Manufacturers Mergers and Acquisitions, Expansion Plans

2.7 Primary Interviews with KeyOral Probiotics Players (Opinion Leaders)

3 Oral Probiotics Retrospective Market Scenario by Region

3.1 Global Oral Probiotics Retrospective Market Scenario in Sales by Region: 2016-2020

3.2 Global Oral Probiotics Retrospective Market Scenario in Revenue by Region: 2016-2020

3.3 North America Market Facts and Figures by Country

3.4 EuropeOral Probiotics Facts and Figures by Country

3.5 Asia Pacific Market Facts and Figures by Region

3.6 Latin America Market Facts and Figures by Country

3.7 the Middle East and Africa Market Facts and Figures by Country

4 Global Oral Probiotics Historic Market Analysis by Type

4.1 Global Sales Market Share by Type (2016-2020)

4.2 Global Revenue Market Share by Type (2016-2020)

4.3 Global Price Market Share by Type (2016-2020)

4.4 Global Market Share by Price Tier (2016-2020)

5 GlobalOral Probiotics Historic Market Analysis by Application

5.1 Global Sales Market Share by Application (2016-2020)

5.2 Global Revenue Market Share by Application (2016-2020)

5.3 Global Price by Application (2016-2020)

..Countinued

Inquire or Share Your Questions If Any before the Purchasing This Report https://www.futuristicreports.com/send-an-enquiry/53001

Our Other Reports:

Murumuru Butter Market by Production Demand, Consumption, Top Regions and Covid-19 Impact by 2026 | Natural Products, Jarchem Industries, Natural Sourcing and Others

Electric Hand Warmer Market Trend, CAGR Status, Forecast and Covid-19 Impact by 2026 | Zippo, Fourheart, Letouch and Others

Compression Fitting Market Analysis, Size, Share and Covid-19 Impact by 2026 | Pegler Yorkshire, FIP, Brennan and Others

Lipstick Market Size, Trends Research Report and Covid-19 Impact by 2026 | LOreal, MAXFACTOR, CHANE and Others

Futuristic Reports

Name: Mark RiveraTel: +1-408-520-9037Email: [emailprotected]

Continue reading here:
Oral Probiotics Market Outlook, Global Key Players and Covid-19 Impact by 2026 | Oragenics, Life Extension, TheraBreath and Others - TechnoWeekly

Some of the best sci-fi movies are layered and complex, while others are confusing beyond belief and demand several rewatches to unravel it all.

Science fiction movies are often meant to be somewhat complicated, and the fanbase is typically made of people who want something challenging they can appreciate. While the movies need to be visually entertaining and raise viewers' emotions, they also need to play to the tropes of the genre to succeed and have long-lasting success.

RELATED:10 Classic Science Fiction Novels That Need A Film Adaptation

However, some science fiction movies have fans scratching their heads in confusion and many of these movies require a second viewing to figure things out. The best science fiction movies award this second viewing with clues placed throughout the film to make it a satisfying experience.

In 2010, Christopher Nolan created one of his top critically acclaimed movies with the mind-bender,Inception. The film stars Leonardo DiCaprio as a thief who steals information using technology that allows him to enter a person's subconscious to gain access to memories that help the companies hire him.

He is offered a chance to erase his criminal past if he implants another person's memories into someone else's head. Despite its complicated premise, it was a huge success and won four Oscars.

Duncan Jones is the son of the late rock-star, David Bowie, but he set out to make his name as a filmmaker without riding the coattails of his father's more famous name.

While he is known for his bigger movies, includingSource Code and Warcraft, he made his debut with what might be his best film,Moon. The movie was shot with a small budget, with Jones doing all the effects. The movie stars Sam Rockwell, a man on a moon mission alone who starts to see visions right before he is set to return home.

Christopher Nolan was back in 2014 with another confusing movie, this one a sci-fi film called Interstellar. When it comes toobscure and complexplot points,Inceptionis child'splay compared to Interstellar's messages and themes.

The movie stars Matthew McConaughey as a man who lives on a future Earth where people struggle to survive. He then joins a group of astronauts who travel to a wormhole by Saturn and end up finding a lot more than they ever dreamed of.

In 2001, Donnie Darkowas the movie that made Richard Kelly the next big thing. The sci-fi movie was so great that Kelly could never live up to its promise afterward. Part of the reason for this was that Kelly tried to re-up the confusing storylines from this first film with the ultra-confusing Southland Tales.

RELATED:10 Sci-Fi Films Even People Who Hate Science Fiction Will Love

Jake Gyllenhaal starred in Donnie Darko as a teen who starts to have doomsday visions. By the end, viewers realize nothing in the movie is as it seemed and a rewatch shows how Donnieunderstood his fate.

Primer is widely considered one of the smartest sci-fi movies ever made. It is also extremely confusing and requires a rewatch to catch everything the filmmakers are trying to convey.

Directed by Shane Carruth, Primer is a movie with a complex and nonlinear plot that uses complex technical dialogue and philosophical science fiction theories. The film is about the accidental discovery of time travel, and it deals with alternate timelines in a very complicated manner.

Released in 2007, the Spanish-language science fiction film Timecrimes confused and enthused fans everywhere.

In this movie, a man named Hector finds himself trapped in a non-stop time loop, and as time goes on, more and more of his selves pop up in the world from the future, and he does what he can to stop these anomalies from appearing. This is yet another time-travel movie that takes multiple watches to piece everything together.

Darren Aronofsky is a director that has made several complicated and intellectual indie-style movies. His first two critically acclaimed movies, Pi and Requiem for a Dream, both tackled complicated subject matter in a way that was very polarizing for some viewers. The Fountain took it to another level.

RELATED:Top 10 Female Protagonists in Science Fiction Movies

Hugh Jackman and Rachel Weisz star in this movie about love and loss of love across three different timelines. It has a touch of fantasy and spirituality, and its hardcore sci-fi storylinemeans there is no way to understandit without watching it two or more times.

Solaris is based on a science fiction novel written in 1961 by Stanislaw Lem about scientists at a research station trying to understand extraterrestrial intelligence on an alien planet.

There were two iterations of this film, the first coming in 1972 by Andrei Tarkovsky and the second in 2002 by Steven Soderbergh. Both are complex films that deal with the scientists' emotional crisis as they try to understand the unknown.

Stanley Kubrick directed one of the seminal sci-fi movies in history with 2001: A Space Odyssey. The film is about a group of people aboard a spacecraft on a trip to Jupiter, alongside a sentient computer named HAL to investigate the possibility of alien life.

When everyone dies except for one person, Dr. David Bowman, he continues the journey with HAL, but soon realizes that HAL might have nefarious plans of its own. By the end, Bowman is having visions and is transforms into a fetus - needless to say, the film requires another watch or two to understand what just happened.

In 2001, Cameron Crowe directed the remake of the 1997 Spanish-language film Open Your Eyes. RenamedVanilla Sky, the movie stars Tom Cruise as a man involved in an accident who wakes up to find his face disfigured.

Penelope Cruz and Cameron Diaz co-star as two women involved in his life, but as he tells his story to a psychologist (Kurt Russell), it appears something has happened to him that he doesn't remember. It all goes off the rails when a company specializing in "life extension" comes into the picture.

NEXT:The 10 Best-Looking Science Fiction Shows Of All Time

Next 10 Best Films That Were Mostly Set In Or Underwater, Ranked According To IMDb

Shawn S. Lealos is a freelance writer who received his Bachelor's degree in Journalism from the University of Oklahoma with a minor in Film Studies. He has worked as a journalist for over 20 years, first in the world of print journalism before moving to online media as the world changed. Shawn is a former member of the Society of Professional Journalists and the Oklahoma Film Critics Circle before relocating to Texas and has work published in the Daily Oklahoman, Oklahoma Gazette, Vox Magazine and Loud Magazine and on websites like The Huffington Post, CBS, Time Warner Cable, Yahoo, The Movie Network, Chud, Renegade Cinema, 411mania and Sporting News. Shawn is also a published author, with a non-fiction book about the Stephen King Dollar Baby Filmmakers and has begun work on a new fiction series as well. Visit Shawn Lealos' website to learn more about his novel writing and follow him on Twitter @sslealos.

Read more here:
10 Sci-Fi Movies That Only Make Sense On A Rewatch | ScreenRant - Screen Rant

GAITHERSBURG, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the three and nine months ended September 30, 2020 and updated its full year 2020 guidance.

Over the last 22 years, Emergent has built a solid business founded on demonstrable strengths in partnering, manufacturing, and integrating value-added M&A, said Robert G. Kramer, president and chief executive officer of Emergent BioSolutions. The strength of our core business and the accelerated growth of our contract development and manufacturing unit validate our strategy to pursue leadership positions across the public health threat market. Our diverse product and service portfolio gives us continued confidence in executing our strategy, delivering on our commitments to our partners and customers, and creating value for our shareholders.

FINANCIAL HIGHLIGHTS (unaudited)

(in millions)

Q3 2020

Q3 2019

$ Change

% Change

Total Revenues

$385.2

$311.8

$73.4

24%

Net Income

$39.5

$43.2

($3.7)

(9)%

Adjusted Net Income (1)

$119.0

$64.8

$54.2

84%

Adjusted EBITDA (1)

$168.1

$106.4

$61.7

58%

(in millions)

YTD 2020

YTD 2019

$ Change

% Change

Total Revenues

$972.4

$745.7

$226.7

30%

Net Income

$119.7

$7.6

$112.1

*

Adjusted Net Income (1)

$225.1

$69.6

$155.5

*

Adjusted EBITDA (1)

$339.5

$145.4

$194.1

*

* % change is greater than 100%

SELECT Q3 2020 BUSINESS ACCOMPLISHMENTS

Completed an offering of $450 million in aggregate principal amount 3.875% Senior Unsecured Notes due in 2028. The Company utilized the proceeds from the offering to repay $353 million outstanding under its revolving credit facility with the remainder to be utilized for general corporate purposes.

Announced the initiation of a Phase 3 clinical trial sponsored by the National Institutes of Health to evaluate the safety, tolerability, and efficacy of hyperimmune globulin products, including the Company's COVID-19 Human Immune Globulin (COVID-HIG), as a potential treatment in adult patients hospitalized with COVID-19.

Announced U.S. Food and Drug Administration (FDA) approval of the shelf life extension of NARCAN (naloxone HCl) Nasal Spray from 24 months to 36 months.

Secured approximately $60 million in new business and existing project extensions across development services, drug substance manufacturing, and drug product manufacturing towards the Company's contract development and manufacturing (CDMO) portfolio.

2020 FINANCIAL PERFORMANCE (unaudited)

Story continues

(I) Quarter Ended September 30, 2020 (Q3)

Revenues

Total Revenues

For Q3 2020, total revenues were $385.2 million, an increase of $73.4 million as compared to 2019. Total revenues reflect an increase in contract development and manufacturing services revenues partially offset by a decrease in product sales and contracts and grants revenues.

Product Sales

For Q3 2020, product sales were $202.2 million, a decrease of $54.0 million or 21% as compared to 2019. Other product sales increased due to increased sales of BAT[Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] and VIGIV [Vaccinia Immune Globulin Intravenous (Human)] offset by a decline in sales of travel health vaccines.

(in millions)

Three Months Ended September 30,

2020

2019

% Change

Product Sales

NARCAN Nasal Spray

$88.8

$75.0

18%

Anthrax vaccines

$73.9

$40.3

83%

ACAM2000

$1.0

$112.1

(99)%

Other

$38.5

$28.8

34%

Total Product Sales

$202.2

$256.2

(21)%

Contract Development and Manufacturing (CDMO) Services

For Q3 2020, revenue from the Companys contract development and manufacturing operations was $157.1 million, an increase of $137.1 million as compared to 2019. The increase is largely due to the contribution of arrangements across development, drug substance manufacturing, and drug product manufacturing services with industry and government customers.

Contracts and Grants

For Q3 2020, revenue from the Companys development-based contracts and grants was $25.9 million, a decrease of $9.7 million as compared to 2019. The decrease primarily reflects the completion of development activities associated with the AV7909 product candidate in 2019, partially offset by recent new development awards related to the Company's COVID-19 product candidates.

Operating Expenses

Cost of Product Sales and Contract Development and Manufacturing (CDMO) Services

For Q3 2020, cost of product sales and contract development and manufacturing services was $149.0 million, an increase of $41.0 million or 38% as compared to 2019. The increase is primarily due to a charge of $29.9 million associated with contingent consideration liabilities due to the increased expectation that the Company will meet its final sales milestone for NARCAN Nasal Spray, a charge of $13.8 million related to a write-down of inventory balances due to the expected expiration of a portion of the Company's travel health vaccines, and an increase in volume in CDMO services offset by a decline in volume of product sales.

Read the original here:
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance - Yahoo...

Dublin, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The "In-Space Manufacturing, Servicing, and Transportation Market - A Global Market and Regional Analysis: Focus on End User, Operation and Country Analysis - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The in-space manufacturing, servicing, and transportation industry analysis projects the market to grow at a significant CAGR of 17.26% on the basis of value during the forecast period from 2020 to 2030. North America is expected to dominate the market in 2030 with a share of 45.57%. The North America region includes the U.S. and Canada. The U.S. is expected to acquire a major share in 2030 due to the increase in the investment and strategic developments of companies in the country.

The technological development and feasibility of on-orbit servicing, repair, inspection, and assembly have already been witnessed in the past decades. There are several factors that are contributing to the significant growth of in-orbit manufacturing, servicing, and transportation market. Some of these factors include focused efforts by emerging space companies to develop on-orbit space capabilities, increasing efforts toward space debris removal, and increasing satellite launches.

The in-space manufacturing, servicing, and transportation market research provides detailed market information for segmentation such as end-user, operation, and region. The purpose of this market analysis is to examine the in-space manufacturing, servicing, and transportation market outlook in terms of factors driving the market, trends, technological developments, and competitive benchmarking, among others.

The report further takes into consideration the market dynamics and the competitive landscape, along with the detailed financial and product contribution of the key players operating in the market.

While highlighting the key driving and restraining forces for this market, the report also provides a detailed study of the end-users, which include commercial and military & government. The report also analyzes different operations that include manufacturing, servicing, and transportation. Furthermore, the service sub-segment is further segmented into life extension, de-orbiting, satellite repair and inspection, and relocation.

The in-space manufacturing, servicing, and transportation market is segregated by region under four major regions, namely North America, Europe, Asia-Pacific, and Rest-of-the-World. Data for each of these regions (by country) has been provided in the market study.

Key Companies in the Global In-Space Manufacturing, Servicing, and Transportation Industry

The key market players in the global in-space manufacturing, servicing, and transportation market include Airbus S.A.S., Altius Space, Astrobotics, Astroscale, Momentus Space, Atomos Space, Chandah Space Technologies, D-Orbit SpA, Honeybee Robotics, Infinite Orbits, Orbit Fab, Northrop Grumman Corporation, SSL (a Maxar Company), Tethers Unlimited, Inc., and Made In Space, among others.

Key Questions Answered in this Report:

Key Topics Covered:

1 Markets1.1 Industry Outlook1.2 Business Dynamics1.2.1 Business Drivers1.2.1.1 Increasing Developments by Emerging Space Players on On-Orbit Space Capabilities1.2.1.2 Focus on In-situ resource utilization (ISRU) for Sustainable Space Infrastructure1.2.1.3 Increased Benefits for Space Missions Through the Adoption of On-Orbit Services1.2.2 Business Challenges1.2.2.1 Technical Challenges Hindering the Potential of On-Orbit Space Capabilities1.2.2.2 Legal and Regulatory Issues1.2.3 Business Strategies1.2.3.1 New Product Development1.2.3.2 Market Developments1.2.4 Corporate Strategies1.2.4.1 Contracts, Agreements, Partnerships, Collaborations, and Acquisitions1.2.5 Business Opportunities1.2.5.1 Increasing Efforts on Space Debris Removal1.2.5.2 Increasing Number of Satellite Launches

2 Application2.1 Demand Analysis of In-Space Manufacturing, Servicing, and Transportation (by End User)2.1.1 Commercial2.1.2 Military and Government

3 Products3.1 Global In-Space Manufacturing, Servicing, and Transportation Market (by Operation)3.2 Demand Analysis of In-Space Manufacturing, Servicing, and Transportation Market (by Operation)3.2.1 Manufacturing3.2.2 Servicing3.2.2.1 Life Extension3.2.2.1.1 Life Extension, By Orbit3.2.2.2 De-Orbiting3.2.2.2.1 De-Orbiting, By Orbit3.2.2.3 Satellite Inspection and Repair3.2.2.3.1 Satellite Inspection and Repair, By Orbit3.2.2.4 Relocation3.2.2.4.1 Relocation, By Orbit3.2.3 Transportation

4 Regions4.1 North America4.2 Europe4.3 Asia-Pacific4.4 Rest-of-the-World

5 Markets - Competitive Benchmarking & Company Profiles5.1 Competitive Benchmarking5.2 Astrobotic Technology, Inc.5.2.1 Company Overview5.2.1.1 Role of Astrobotic Technology, Inc. in In-Space Manufacturing, Servicing, and Transportation Market5.2.2 Corporate Strategies5.2.2.1 Partnerships and Collaborations5.2.2.2 Contracts and Agreements5.2.3 Strength and Weakness of Astrobotic Technology, Inc.5.3 Airbus5.3.1 Company Overview5.3.1.1 Role of Airbus in In-Space Manufacturing, Servicing, and Transportation Market5.3.1.2 Product Portfolio5.3.1.3 Production Sites5.3.2 Corporate Strategies5.3.2.1 Partnerships and Collaborations5.3.2.2 Contracts and Agreements5.3.3 Strength and Weakness of Airbus5.3.4 R&D Analysis5.4 Altius Space Machines Inc.5.4.1 Company Overview5.4.1.1 Role of Altius Space Machines Inc. in In-Space Manufacturing, Servicing, and Transportation Market5.4.1.2 Product Portfolio5.4.2 Corporate Strategies5.4.2.1 Contracts and Agreements5.4.3 Strength and Weakness of Altius Space Machines Inc.5.5 Astroscale5.5.1 Company Overview5.5.1.1 Role of Astroscale in In-Space Manufacturing, Servicing, and Transportation Market5.5.1.2 Product Portfolio5.5.1.3 Production Sites5.5.2 Business Strategies5.5.2.1 Market Developments5.5.3 Corporate Strategies5.5.3.1 Partnerships and Collaborations5.5.3.2 Contract and Agreement5.5.4 Strength and Weakness of Astroscale5.6 Atomos Space5.6.1 Company Overview5.6.1.1 Role of Atomos Space in In-Space Manufacturing, Servicing, and Transportation Market5.6.1.2 Product Portfolio5.6.2 Strength and Weakness of Atomos Space5.7 Chandah Space Technologies5.7.1 Company Overview5.7.1.1 Role of Chandah Space Technologies in In-Space Manufacturing, Servicing, and Transportation Market5.7.2 Strength and Weakness of Chandah Space Technologies5.8 D-Orbit5.8.1 Company Overview5.8.1.1 Role of D-Orbit in In-Space Manufacturing, Servicing, and Transportation Market5.8.1.2 Product Portfolio5.8.2 Business Strategies5.8.2.1 Product Developments5.8.3 Strength and Weakness of D-Orbit5.9 Honeybee Robotics5.9.1 Company Overview5.9.1.1 Role of Honeybee Robotics in In-Space Manufacturing, Servicing, and Transportation Market5.9.1.2 Product Portfolio5.9.1.3 Production Sites5.9.2 Corporate Strategies5.9.2.1 Contracts and Agreements5.9.3 Strength and Weakness of Honeybee Robotics Corporation5.1 Infinite Orbits5.10.1 Company Overview5.10.1.1 Role of Infinite Orbits in In-Space Manufacturing, Servicing, and Transportation Market5.10.1.2 Product Portfolio5.10.2 Strength and Weakness of Infinite Orbits5.11 Orbit Fab5.11.1 Company Overview5.11.1.1 Role of Orbit Fab in In-Space Manufacturing, Servicing, and Transportation Market5.11.1.2 Product Portfolio5.11.2 Corporate Strategies5.11.2.1 Contracts and Agreements5.11.3 Strength and Weakness of Orbit Fab5.12 Northrop Grumman Corporation5.12.1 Company Overview5.12.1.1 Role of Northrop Grumman Corporation in In-Space Manufacturing, Servicing, and Transportation Market5.12.1.2 Product Portfolio5.12.2 Corporate Strategies5.12.2.1 Partnerships and Collaborations5.12.2.2 Contracts and Agreements5.12.3 Strength and Weakness of Northrop Grumman Corporation5.12.4 R&D Analysis5.13 Tethers Unlimited Inc.5.13.1 Company Overview5.13.1.1 Role of Tethers Unlimited Inc. in In-Space Manufacturing, Servicing, and Transportation Market5.13.1.2 Product Portfolio5.13.2 Business Strategies5.13.2.1 Product Developments5.13.3 Corporate Strategies5.13.3.1 Contracts and Agreements5.13.4 Strength and Weakness of Tethers Unlimited Inc.5.14 SSL (Maxar Technologies Company)5.14.1 Company Overview5.14.1.1 Role of SSL (Maxar Technologies Company) in In-Space Manufacturing, Servicing, and Transportation Market5.14.1.2 Product Portfolio5.14.2 Strength and Weakness of SSL (Maxar Technologies Company)5.15 Made In Space5.15.1 Company Overview5.15.1.1 Role of Made In Space in In-Space Manufacturing, Servicing, and Transportation Market5.15.1.2 Product Portfolio5.15.2 Business Strategies5.15.2.1 Product Developments5.15.3 Corporate Strategies5.15.3.1 Contracts and Agreements5.15.4 Strength and Weakness of Made In Space5.16 Momentus Space5.16.1 Company Overview5.16.1.1 Role of Momentus Space in In-Space Manufacturing, Servicing, and Transportation Market5.16.1.2 Product Portfolio5.16.2 Corporate Strategies5.16.2.1 Partnerships and Collaborations5.16.2.2 Contracts and Agreements5.16.3 Strength and Weakness of Momentus Space

6 Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/zdqqr7

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

See the original post:
Insights on the In-Space Manufacturing, Servicing, and Transportation Global Market to 2030 - Increasing Developments in On-Orbit Space Capabilities...

MJR Power & Automation has successfully completed the life extension project of the trailing suction hopper dredger (TSHD) Heortnesse, owned and operated by PD Ports.

Under the project, MJR delivered the complete electrical power, propulsion, dredging & integrated control, automation & monitoring system upgrade including Lloyds class approval in an aggressive 7 month project schedule from design through to installation and commissioning.

A&P Group awarded MJR the contract in late September 2019 after an extensive competitive tender process against leading global marine companies for thedesign and replacement of the vessels entire diesel electric propulsion, dredging and automation plant.

MJR was contracted to deliver a complete turnkey package including engineering, procurement, installation & commissioning with full design approval by Lloyds Register of Shipping.

The design, engineering and procurement was carried out during the 4th quarter of 2019 followed by the construction, automation and FAT during the early part of 2020 at MJRs HQ in Stockton-on-Tees.

Installation and commissioning teams completed the site works at A&Ps Tees docks, Middlesbrough during March 2020 and April followed by successful trials in May 2020.

Read this article:
MJR completes work on TSHD Heortnesse - Dredging Today

Databridgemarketresearch.com announces the release of the report Global Glucose Tolerance Test Market Size, Share & Trends Analysis Report By 2027. The market data analysed and evaluated in the world class Global Glucose Tolerance Test Market report makes to achieve the business goals and objectives in preset time frame. This market research report endows with productive ideas which in turn help to make the product more effective and striking in the competitive market. This report covers the specific study of the industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. The Global Glucose Tolerance Test Market research report takes into account key product developments and tracks recent acquisitions, mergers and research in the industry by the key market players.

Global Glucose Tolerance Test Market is set to witness a healthy CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Increasing diabetic cases worldwide is driving the growth of this market.

DOWNLOAD FREE PDF SAMPLE COPY OFREPORT@HTTPS://DATABRIDGEMARKETRESEARCH.COM/REQUEST-A-SAMPLE/?DBMR=GLOBAL-GLUCOSE-TOLERANCE-TEST-MARKET

Global Glucose Tolerance Test Market By Product (Smart Sensors, Blood Glucose Testing Kit, Others), Indication (Reactive Hypoglycemia, Gestational Diabetes, Diabetes, Insulin Resistance,), End-User (Hospitals, Home, Diagnostic Clinics, Others), Geography (South America, North America, Europe, Middle East & Africa, Asia-Pacific) Industry Trends and Forecast to 2026

Competitive Analysis:

Global glucose tolerance test market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of glucose tolerance test market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Major Market Competitors/Players:

Some of the major players operating in the global glucose tolerance test market are Thermo Fisher Scientific Inc., Medtronic, NIPRO, Trividia Health, Inc., Dexcom, Inc., Dorevitch Pathology, Penlan Healthcare Ltd, Quest Diagnostics Incorporated, Johnson & Johnson Services, Inc., Abbott, Laboratory Corporation of America Holdings., ARUP Laboratories., Cleveland HeartLab, Inc., Merck KGaA, Bayer AG, Life Extension, and among others.

Market Definition: Global Glucose Tolerance Test Market

The capability to absorb glucose (Sugar) from our body cells after the consumption of some amount of sugar is measured with the help of glucose tolerance test. This test is used to diagnose diabetes. It has its major application in screening all pregnant women for gestational diabetes, as it can cause further complications during pregnancy. So early detection and prompt treatment are important. Fasting blood sugar levels and haemoglobin A1C values are used by doctors to diagnose type 1 and type 2 diabetes as well as prediabetes.

Market Drivers:

Market Restraints:

Key Development in the Market:

Order a Copy of This ResearchReport @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-glucose-tolerance-test-market

Segmentation: Global Glucose Tolerance Test Market

Reasons to Purchase this Report

Customization of the Report

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

Read the original:
Global Glucose Tolerance Test Market 2020 Covid 19 Analysis, Market Size, Market Growth, Competitive Strategies, and Worldwide Demand 2027 - BCFocus

Global Lingonberry Extract Industry: with growing significant CAGR during Forecast 2020-2027

Latest Research Report on Lingonberry Extract Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis

Understand the influence of COVID-19 on the Lingonberry Extract Market with our analysts monitoring the situation across the globe. Request Now

The market research report on the global Lingonberry Extract industry provides a comprehensive study of the various techniques and materials used in the production of Lingonberry Extract market products. Starting from industry chain analysis to cost structure analysis, the report analyzes multiple aspects, including the production and end-use segments of the Lingonberry Extract market products. The latest trends in the pharmaceutical industry have been detailed in the report to measure their impact on the production of Lingonberry Extract market products.

Leading key players in the Lingonberry Extract market are Shanghai Freemen, Natrol, Source Naturals, Swanson, Life Extension, Athelas Nutraceuticals, Bio Botanica, Dongling Health Food

Get sample of this report @ https://grandviewreport.com/sample/36564

Product Types:Powder, Granular

By Application/ End-user:Food Industry, Pharmaceuticals Industry, Other

Regional Analysis For Lingonberry Extract Market

North America(the United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Get Discount on Lingonberry Extract report @ https://grandviewreport.com/discount/36564

This report comes along with an added Excel data-sheet suite taking quantitative data from all numeric forecasts presented in the report.

Research Methodology:The Lingonberry Extract market has been analyzed using an optimum mix of secondary sources and benchmark methodology besides a unique blend of primary insights. The contemporary valuation of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary members have helped in compiling appropriate aspects with realistic parametric assessments for a comprehensive study.

Whats in the offering: The report provides in-depth knowledge about the utilization and adoption of Lingonberry Extract Industries in various applications, types, and regions/countries. Furthermore, the key stakeholders can ascertain the major trends, investments, drivers, vertical players initiatives, government pursuits towards the product acceptance in the upcoming years, and insights of commercial products present in the market.

Full Report Link @ https://grandviewreport.com/industry-growth/Lingonberry-Extract-Market-36564

Lastly, the Lingonberry Extract Market study provides essential information about the major challenges that are going to influence market growth. The report additionally provides overall details about the business opportunities to key stakeholders to expand their business and capture revenues in the precise verticals. The report will help the existing or upcoming companies in this market to examine the various aspects of this domain before investing or expanding their business in the Lingonberry Extract market.

Contact Us:Grand View Report(UK) +44-208-133-9198(APAC) +91-73789-80300Email : [emailprotected]

Read more here:
Lingonberry Extract Market: Qualitative analysis of the leading players and competitive industry scenario | Shanghai Freemen, Natrol, Source Naturals,...

DataIntelo has published a latest market research report on Global Cryonics Technology Market. The global report is prepared in collaboration with the leading industry experts and dedicated research analyst team to provide an enterprise with in-depth market insights and help them to take crucial business decisions. This report covers current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market.

The published report explains about the current supply and demand scenario and presents the future outlook of the market in a detailed manner. DataIntelo has applied a robust market research methodology to bestow the new entrants and emerging players with 360 wide-view analysis on the latest advancements and their impacts on the market. It has congregated massive amount of data on the key segments of the market in an easy to understand format. The research report has laid out the numbers and figures in a comprehensive manner with the help of graphical and pictorial representation which embodies more clarity on the market.

You can buy this complete report @ https://dataintelo.com/checkout/?reportId=92114

Report Covers Impacts of COVID-19 to the market.

The on-going pandemic has overhauled various facets of the market. This research report provides the financial impacts and market disturbance on the Cryonics Technology market. It also includes analysis on the potential lucrative opportunities and challenges in the foreseeable future. DataIntelo has interviewed various delegates of the industry and got involved in the primary and secondary research to confer the clients with information and strategies to fight against the market challenges amidst and after COVID-19 pandemic.

Market Segmentation:

Few of the companies that are covered in the report.

PraxairCellulisCryologicsCryothermKrioRusVWRThermo Fisher ScientificCustom Biogenic SystemsOregon CryonicsAlcor Life Extension FoundationOsiris CryonicsSigma-AldrichSouthern Cryonics

Note: Additional companies can be included in the list upon the request.

By Product Type:

Slow freezingVitrificationUltra-rapid

By Applications:

Animal husbandryFishery scienceMedical sciencePreservation of microbiology cultureConserving plant biodiversity

By Geographical Location:Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Get A Free Sample Report @ https://dataintelo.com/request-sample/?reportId=92114

The research report provides a detailed analysis of the prominent player in the market, products, applications, and regional analysis which also include impacts of government policies in the market. Moreover, you can sign up for the yearly updates on the Cryonics Technology market.

7 Reasons for Buying Cryonics Technology Market Report

If you have any query regarding the report, ask our experts: @ https://dataintelo.com/enquiry-before-buying/?reportId=92114

Below is the TOC of the report:

Cryonics Technology Supply Chain Analysis

Cryonics Technology Pricing Analysis

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo

See the original post here:
Cryonics Technology Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - The Think Curiouser

The COVID-19 Outbreak:Global Antioxidant Supplement Market to witnessed good recovery in growth and projected coverup market sizing during the forecast period (2020-2026). The assessment provides a 360 view and insights outlining the key outcomes of the Antioxidant Supplement market, current scenario analysis that highlights slowdown aims to provide unique strategies and solutions following and benchmarking key players strategies. In addition, the study helps with competition insights of emerging players in understanding the companies more precisely to make better informed decisions. Some of the key players that are part of coverage are NOW, Vibrant Health, AST R-ALA, GNC, Jarrow Formulas, Life Extension.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets

Get Free Sample Copy of This Research Report:https://www.readmarketresearch.com/sample-request/37406-world-antioxidant-supplement-market

On the basis ofProduct, this report displays the production, revenue, price, market share and growth rate of each type:

Medical Grade, Food Grade

On the basis ofApplications, the market has been segmented into:

Medical, Food, Cosmetics

TopCompaniescovered in the report:NOW, Vibrant Health, AST R-ALA, GNC, Jarrow Formulas, Life Extension

Read Full TOC of Antioxidant Supplement Research Study at @www.readmarketresearch.com/industry-report/37406/world-antioxidant-supplement-market

Research Methodology:

Years considered for the study are:Historical year 2016-2019Disreputable year 2020Estimate period** 2020 to 2025 [** unless otherwise stated]

Primary Research:

The primary sources involve the industry experts from the Global Antioxidant Supplement industry including the management organizations, processing organizations, analytics service providers of the industrys value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.In the extensive primary research process undertaken for this study, the primary sources industry experts such as CEOs, vice presidents, marketing director, technology & innovation directors, founders and related key executives from various key companies and organizations in the Global Antioxidant Supplement industry have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

Secondary Research:

In the Secondary research crucial information about the industries value chain, total pool of key players, and application areas. It also assisted in market segmentation according to industry trends to the bottom-most level, geographical markets and key developments from both market and technology-oriented perspectives.

Table of ContentsGlobal Antioxidant Supplement Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

1 Antioxidant Supplement Market Overview1.1 Introduction1.2 Scope1.3 Assumptions1.4 Players Covered1.5 Market Analysis By Type1.5.1 Global Antioxidant Supplement Market Size Growth Rate By Type (2020-2025)1.5.2 1.5.3 1.5.4 1.6 Market By Application1.6.1 Global Antioxidant Supplement Market Share By Application (2020-2025)1.6.2 Application I1.6.3 Application Ii1.6.4 1.7 Study Objectives1.8 Years

2 Executive Summary

3 Antioxidant Supplement Market Analysis By Type (Historic 2016-2019)3.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-20193.1.1 Type I3.1.2 Type Ii3.1.3 Type Iii3.2 Global Antioxidant Supplement Market Share Analysis By Type (%) 2016-2019

4 Antioxidant Supplement Market Analysis By Application (Historic 2016-2019)4.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-2019

5 Antioxidant Supplement Market Analysis By Regions (Historic 2016-2019)5.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-20195.1.1 Antioxidant Supplement Market Share By Regions (2016-2019)5.1.2 United States5.1.3 Europe5.1.4 China5.1.5 Japan5.1.6 India5.1.7 Rest Of The World

6 Key Companies Analysis/Company Profile

Continued..

Buy the Up-to-date Full Report @www.readmarketresearch.com/checkout?buynow=37406

Key Questions Answered by Antioxidant Supplement Market Report

1. What was the Antioxidant Supplement Market size in 2018 and 2019; what are the estimated growth trends and market forecast (2020-2025).2. What will be the CAGR of Antioxidant Supplement Market during the forecast period (2020-2025)?3. Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2020-2025).4. Which manufacturer/vendor/players in the Data Management Platform Market was the market leader in 2019?5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Enquire for Discount in Report @www.readmarketresearch.com/check-discount/37406-world-antioxidant-supplement-market*Get Upto $1000 Flat Discount on All License Type.

About UsWe at Read offers wide range of business services including but not limited to Market Research, Syndicate and Custom Research, Company Research, Business Consulting, Audit & Risk, Communications, Finance, Information Technology, Legal & Compliance, Human Resources and Sales.

Contact:Read Market ResearchDev Dixit (Sales Manager)B-51 CMPDI, Korba, ChhattisgarhPhone: +1 646 583 1932Email:[emailprotected]Web:https://www.readmarketresearch.comFollow Us on:LinkedIN

Go here to read the rest:
Antioxidant Supplement Market 2026 Industry Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global...

Overview for Bilberry Extract Products Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics

The Bilberry Extract Products market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bilberry Extract Products market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Bilberry Extract Products market. The report focuses on well-known providers in the global Bilberry Extract Products industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Bilberry Extract Products Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter 2.4, we analyzed industry trends in the context of COVID-19., In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets., In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries., In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Download PDF Sample of Bilberry Extract Products Market report @ https://www.arcognizance.com/enquiry-sample/1481413

Key players in the global Bilberry Extract Products market covered in Chapter 4:, Natrol Vitamins & Supplements, Nutraceutical, Nutrilite, Life Extension, Spring Valley, Kanbo Natural Health Food, Natures Way Products, LLC., Puritans Pride, Source Naturals, Inc., Biofinest, Now foods, Ahana Nutrition, GNC, Bluebonnet Nutrition, Swanson

In Chapter 11 and 13.3, on the basis of types, the Bilberry Extract Products market from 2015 to 2026 is primarily split into:, Tablets, Cheweables, Others

In Chapter 12 and 13.4, on the basis of applications, the Bilberry Extract Products market from 2015 to 2026 covers:, E-commerce, Medical Institutions, Supermarket

[emailprotected] https://www.arcognizance.com/discount/1481413

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:, North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe (Covered in Chapter 7 and 13), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 8 and 13), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 9 and 13), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 10 and 13), Brazil, Argentina, Columbia, Chile, Others

Years considered for this report:, Historical Years: 2015-2019, Base Year: 2019, Estimated Year: 2020, Forecast Period: 2020-2026

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Bilberry Extract Products Market

Chapter Four: Players Profiles

Chapter Five: Global Bilberry Extract Products Market Analysis by Regions

[emailprotected]https://www.arcognizance.com/purchase/1481413

Chapter Six: North America Bilberry Extract Products Market Analysis by Countries

Chapter Seven: Europe Bilberry Extract Products Market Analysis by Countries

Chapter Eight: Asia-Pacific Bilberry Extract Products Market Analysis by Countries

Chapter Nine: Middle East and Africa Bilberry Extract Products Market Analysis by Countries

Chapter Ten: South America Bilberry Extract Products Market Analysis by Countries

Chapter Eleven: Global Bilberry Extract Products Market Segment by Types

Chapter Twelve: Global Bilberry Extract Products Market Segment by Applications12.1 Global Bilberry Extract Products Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Bilberry Extract Products Sales and Market Share by Applications (2015-2020)12.1.2 Global Bilberry Extract Products Revenue and Market Share by Applications (2015-2020)12.2 E-commerce Sales, Revenue and Growth Rate (2015-2020)12.3 Medical Institutions Sales, Revenue and Growth Rate (2015-2020)12.4 Supermarket Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Bilberry Extract Products Market Forecast by Regions (2020-2026) continue

List of tablesList of Tables and FiguresTable Global Bilberry Extract Products Market Size Growth Rate by Type (2020-2026)Figure Global Bilberry Extract Products Market Share by Type in 2019 & 2026Figure Tablets FeaturesFigure Cheweables FeaturesFigure Others FeaturesTable Global Bilberry Extract Products Market Size Growth by Application (2020-2026)Figure Global Bilberry Extract Products Market Share by Application in 2019 & 2026Figure E-commerce DescriptionFigure Medical Institutions DescriptionFigure Supermarket DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Bilberry Extract Products Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Bilberry Extract Products Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Bilberry Extract ProductsFigure Production Process of Bilberry Extract ProductsFigure Manufacturing Cost Structure of Bilberry Extract ProductsFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table Natrol Vitamins & Supplements ProfileTable Natrol Vitamins & Supplements Production, Value, Price, Gross Margin 2015-2020Table Nutraceutical ProfileTable Nutraceutical Production, Value, Price, Gross Margin 2015-2020Table Nutrilite ProfileTable Nutrilite Production, Value, Price, Gross Margin 2015-2020Table Life Extension ProfileTable Life Extension Production, Value, Price, Gross Margin 2015-2020Table Spring Valley ProfileTable Spring Valley Production, Value, Price, Gross Margin 2015-2020Table Kanbo Natural Health Food ProfileTable Kanbo Natural Health Food Production, Value, Price, Gross Margin 2015-2020Table Natures Way Products, LLC. ProfileTable Natures Way Products, LLC. Production, Value, Price, Gross Margin 2015-2020Table Puritans Pride ProfileTable Puritans Pride Production, Value, Price, Gross Margin 2015-2020Table Source Naturals, Inc. ProfileTable Source Naturals, Inc. Production, Value, Price, Gross Margin 2015-2020Table Biofinest ProfileTable Biofinest Production, Value, Price, Gross Margin 2015-2020Table Now foods ProfileTable Now foods Production, Value, Price, Gross Margin 2015-2020Table Ahana Nutrition ProfileTable Ahana Nutrition Production, Value, Price, Gross Margin 2015-2020Table GNC ProfileTable GNC Production, Value, Price, Gross Margin 2015-2020Table Bluebonnet Nutrition ProfileTable Bluebonnet Nutrition Production, Value, Price, Gross Margin 2015-2020Table Swanson ProfileTable Swanson Production, Value, Price, Gross Margin 2015-2020Figure Global Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Global Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table Global Bilberry Extract Products Sales by Regions (2015-2020)Table Global Bilberry Extract Products Sales Market Share by Regions (2015-2020)Table Global Bilberry Extract Products Revenue ($) by Regions (2015-2020)Table Global Bilberry Extract Products Revenue Market Share by Regions (2015-2020)Table Global Bilberry Extract Products Revenue Market Share by Regions in 2015Table Global Bilberry Extract Products Revenue Market Share by Regions in 2019Figure North America Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Europe Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Asia-Pacific Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Middle East and Africa Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure South America Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure North America Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table North America Bilberry Extract Products Sales by Countries (2015-2020)Table North America Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure North America Bilberry Extract Products Sales Market Share by Countries in 2015Figure North America Bilberry Extract Products Sales Market Share by Countries in 2019Table North America Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table North America Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure North America Bilberry Extract Products Revenue Market Share by Countries in 2015Figure North America Bilberry Extract Products Revenue Market Share by Countries in 2019Figure United States Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Canada Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Mexico Bilberry Extract Products Sales and Growth (2015-2020)Figure Europe Bilberry Extract Products Revenue ($) Growth (2015-2020)Table Europe Bilberry Extract Products Sales by Countries (2015-2020)Table Europe Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure Europe Bilberry Extract Products Sales Market Share by Countries in 2015Figure Europe Bilberry Extract Products Sales Market Share by Countries in 2019Table Europe Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table Europe Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure Europe Bilberry Extract Products Revenue Market Share by Countries in 2015Figure Europe Bilberry Extract Products Revenue Market Share by Countries in 2019Figure Germany Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure UK Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure France Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Italy Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Spain Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Russia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Asia-Pacific Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table Asia-Pacific Bilberry Extract Products Sales by Countries (2015-2020)Table Asia-Pacific Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Bilberry Extract Products Sales Market Share by Countries in 2015Figure Asia-Pacific Bilberry Extract Products Sales Market Share by Countries in 2019Table Asia-Pacific Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries in 2015Figure Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries in 2019Figure China Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Japan Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure South Korea Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Australia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure India Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Southeast Asia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Middle East and Africa Bilberry Extract Products Revenue ($) and Growth (2015-2020)continue

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:Ranjeet DengaleDirector SalesAnalytical Research Cognizance+1 (646) 403-4695, +91 90967 44448Email: [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Bilberry Extract Products :

Read the original here:
Impact Of Covid 19 On Bilberry Extract Products Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026 - TechnoWeekly

This week, the situation surrounding the review remained in doubt, with the Secretary of State for Defence Ben Wallace telling Parliament that the government was still assessing the implications of scrapping the multi-year spending review.

MPs and experts have expressed concern that only funding the Ministry of Defence (MOD) for a year would further postpone long-awaited spending decisions and add to a black hole in the departments modernisation budget.

Before the Covid-19 coronavirus pandemic struck, the UK had planned to publish the Integrated Review alongside a comprehensive spending review which would have set the MODs budget for four years, giving it room to make spending decisions.

On Monday, Wallace told MPs: The government announced on 21 October that they will conduct a one-year spending review for 2021-22. The implications of that decision for the integrated review are currently being considered. The government will provide an update to Parliament once this has been decided.

Labours Shadow Defence Minister John Healey criticised the confusion around the state of the review, saying: Is it not the regrettable truth that the Chancellor has cut the ground from under the Defence Secretary and our British forces? The Secretary of State rightly said that previous Tory defence reviews have failed because they were never in step with the spending plans.

They were a cover for cuts, which is why our armed forces are nearly 12,000 short of the strength promised in the 2015 review; essential equipment, from new tanks to the new radar system protecting our aircraft carrier, is long overdue; and the defence budget has a 13 billion black hole. A fully-fledged, fully funded strategic defence and security review is needed now more than ever. What does he say about the failure to deliver on that?

Wallace responded saying that no one has said yet that the integrated review will be delayed or curtailed but added that the government was studying the implications a one-year spending review would have.

Critical decisions on the future of the UKs Armed Forces are wrapped up in the Integrated Review, including the future of the British Armys main battle tank and infantry fighting vehicle (IFV) modernisation programmes. The army is in the final stages of negotiating contracts for the Warrior Capability Sustainment Programme (CSP) and Challenger 2 Life Extension Programme (LEP).

The British Army introduced Challenger 2 into service in 1998, and Warrior in 1984. Decisions on both upgrade programmes would likely have to be put off if the MOD only received a one-year budget.

MP and Chair of Parliaments Defence Select Committee Tobias Ellwood told Parliament that a one-year funding settlement would make the integrated review next to meaningless.

He added: The Prime Minister gave me a direct assurance that the integrated review would not be delayed. If global Britain is an instruction and not a strapline, this review is the road map to how we advance our defence posture to support our foreign policy ambitions.

Any delay to its publication with its full spending commitments will send a poor signal to the world that we are absolutely serious about re-establishing our global credentials and could prompt questions about our justification to retain a permanent seat on the UN Security Council.

The Prime Minister and the Defence Secretary have reportedly been pushing the Treasury to commit to a multi-year spending plan for defence.

In a paper published by the Royal United Services Institute (RUSI) titled A Reckoning Postponed? The Defence Arithmetic of the Integrated Review, the thinktanks deputy director-general Malcolm Chalmers wrote that the decision to abandon the multi-year spending review had thrown the Integrated Review into disarray.

Chalmers added that for defence, this decision would mean key decisions on long-term priorities would have to be pushed back to 2021 or 2022.

Chalmers added: A multi-year CSR, combined with a government committed to a radical foreign and defence policy review, would have provided the MoD with an important opportunity to get in front of these issues in relation to these two major programmes, as in other elements of the forward programme.

Now that the government has reverted to a one-year Spending Review, it will be harder to close on the key decisions that need to be taken. There is a risk that, despite the hard work that has gone into the 2020 Integrated Review, and the MDP before it, the MOD may have to repeat the exercise with a new Integrated Review (or at least a defence element of it) in summer 2021 or 2022. Such an outcome would not be good for defence, and it is likely to be bad value for money for the taxpayer.

CBRN Decontamination Equipment

Ground-based Air Defence Systems

Practice Grenades for Military Training

See original here:
Funding questions loom over the UK's Integrated Review - Army Technology

BROOKINGS What if damaged precast concrete bridge columns and building beams or columns could be replaced instead of having to demolish the structure?

That is the possibility a South Dakota State University graduate student and his adviser are looking at. Kallan Hart is a first-year graduate student from Faribault, Minnesota, who earned his bachelors in civil engineering in 2019. Mostafa Tazarv is an assistant professor in the Department of Civil and Environmental Engineering within the Jerome J. Lohr College of Engineering.

Work has just begun on the project, which is largely being funded by an award from the Precast/Prestressed Concrete Institute. Hart received the $40,000 Dennis Mertz Bridge Research Fellowship for 2020-21 and became the first SDSU student to receive an award from the institute. It is to cover his tuition, fees and living expenses as well as project costs.

Supplemental funds come from the National Center for Transportation Infrastructure Durability and Life Extension.

They will undertake a two-year study within the Lohr Structures Lab on campus in cooperation with industry partner Gage Brothers Concrete, Sioux Falls.

Tazarv explained steel bars are traditionally embedded within the columns or beams of a concrete structure. However, when a catastrophic event, such an earthquake, hits the structures, those bars often yield, and sometimes buckle or fracture. When the damage is extensive, the entire structure must be demolished, he explained. Hart and Tazarv will experiment placing the bars on the outside of the bridge columns, which are the main source of resistance against earthquakes and other extreme events.

Their theory is that those bars could be replaced while leaving the structure in place and saving millions of dollars as a result.

In initial testing in the Lohr Structures lab, Tazarv said the proposed repairable precast connections were investigated through cyclic testing of four half-scale beam-column specimens detailed based on a nine-story building designed for Los Angeles, which is a high seismic region. A reference cast-in-place beam-column specimen was also included for comparison.

The test results showed the repairable precast connections can withstand more than 14 times the design level earthquake with insignificant damage and ability to be repaired afterward.

Furthermore, Tazarv found precast buildings using the repairable technology can withstand extreme earthquakes with minimal damage and repair need. Now, it is the time to test the idea on bridges.

In the next two years, Hart will develop 10 new repairable details for bridge columns, rank them based on constructability, cost and expected performance, and test the top two repairable columns, each 10-feet tall, to failure.

Hart is excited to begin the research and be selected for the award.

Assisting on work in the lab the past few months has given me new insight into the seismic applications of structural engineering, despite residing in a low-seismic zone. Hopefully, our new detailing will provide transportation departments and other bridge owners an additional design option to reduce replacement costs in the inevitable event of an earthquake in high-seismic zones while also cutting the amount of time that bridges will have to be closed to the public, Hart said.

Tazarv called Hart a smart, outstanding and hardworking student. This fellowship will provide him an opportunity to perform an innovative research and also benefit from the industry partnership planned in the project.

Read the original post:
Brookings Register | Theory: Replaceable bars could save millions - Brookings Register

Introduction: Global Cryonics Technology Market, 2020-27

This in-depth research report presentation on Global Cryonics Technology market offers decisive market intelligence across multi-tier levels comprising regional, industry level, followed by further supply chain landscape.

The report is thoroughly structured to ensure ample understanding and information flow on new technological milestones, novel product expansion schemes as well as pipeline activities and investments likelihood besides regulatory developments that collectively influence a steady and robust growth trail in global Cryonics Technology market. Additional details such as consumer behavior, top stimulants as well as notable barriers that also tend to mold growth prognosis in global Cryonics Technology market.

Vendor LandscapeThe report draws references of an extensive analysis of the Cryonics Technology market, entailing crucial details about key market players, complete with a broad overview of expansion probability and expansion strategies.PraxairCellulisCryologicsCryothermKrioRusVWRThermo Fisher ScientificCustom Biogenic SystemsOregon CryonicsAlcor Life Extension FoundationOsiris CryonicsSigma-AldrichSouthern Cryonics

Available Sample Report in PDF Version along with Graphs and [emailprotected] https://www.orbismarketreports.com/sample-request/61891?utm_source=Puja

Unbiased research findings suggest an optimistic growth in global Cryonics Technology market securing a decent growth valuation and impressive CAGR percentage which is further anticipated to continue through the forecast span. These crucial report contents suggest that the aforementioned Cryonics Technology market is likely to overcome and emerge successfully from the pandemic constraints and echo favorable growth trajectory of the past decades.

Global Cryonics Technology Market: Type & Application based Analysis

Analysis by Type: This section of the report includes factual details pertaining to the most lucrative segment harnessing revenue maximization.Slow freezingVitrificationUltra-rapid

Analysis by Application: Further in the subsequent sections of the report, research analysts have rendered precise judgment regarding the various applications that the Cryonics Technology market mediates for superlative end-user benefits.Animal husbandryFishery scienceMedical sciencePreservation of microbiology cultureConserving plant biodiversity

Reader Centric Queries: Global Cryonics Technology Market

The report showcases a detailed overview and scenario evaluation of the global Cryonics Technology market for the period, 2020-25

Accurate CAGR predictions through the forecast tenure, 2020-25

A clear understanding and analytical review of all the dominant factors that are likely to assist and ensure steady growth trail in global Cryonics Technology market during the next five years

Growth estimations in terms of value and volume-based growth across regions as well as global scenario

Read complete report along with TOC @ https://www.orbismarketreports.com/global-cryonics-technology-market-size-status-and-forecast-2019-2025?utm_source=Puja

COVID-19 Impact AnalysisThis intensively researched report presentation has been prepared in real time parlance, rendering substantial attention towards COVID-19 outbreak that has lately wreaked unprecedented damage across industries, stagnating growth.

The report lends attention towards evaluating the market in terms of exhaustive research in the times of COVID, as well as devising appropriate come back protocols to restore normalcy.

Decoding Regional Overview of the Cryonics Technology MarketApart from gauging into the present as well as future implications of COVID, the report is a dependable document to understand the dormant opportunities, new products and services that are likely to be more relevant in the post COVID-19 market. This section of the report therefore shares vital details and workable cues on new product profiles to help businesses revive from the COVID aftermath.

Report Deliverable: Global Cryonics Technology Market

This detailed and versatile report synopsis on global Cryonics Technology market has been prepared on the basis of thorough research studies, summation and synthesispractices after collating information from multiple sources. In essence, this Cryonics Technology market report presents data in the following categories:

Market size estimation at global and regional levels

Dominant and popular trends

A thorough analysis based on geographical expanse to identify top growth hotspots.

The report includes sections about growth probabilities that represent major disruptions.

In-depth research findings reflected in this report opine that despite the unprecedented outbreak and lingering implications of COVID-19 and its reformatory reforms reflected across industries, the immediate and future specific implications have been thoroughly classified and elaborated in the report to encourage unbiased market discretion.

Some Major TOC Points: Chapter 1. Report Overview Chapter 2. Global Growth Trends Chapter 3. Market Share by Key Players Chapter 4. Breakdown Data by Type and Application Chapter 5. Market by End Users/Application Chapter 6. COVID-19 Outbreak: Cryonics Technology Industry Impact Chapter 7. Opportunity Analysis in Covid-19 Crisis Chapter 9. Market Driving ForceAnd Many More

A dedicated chapter on COVID-19 analysis has therefore been included in this versatile report to encourage future-ready business discretion aligning with post COVID-19 market environment.

Shoot your queries at:@ https://www.orbismarketreports.com/enquiry-before-buying/61891?utm_source=Puja

Market Report Offerings in a Gist: A thorough reference of the dominant trends as well as relevant market dynamics Elaborate analysis and reference of core products and dynamic segments A thorough analysis of the competition spectrum and winning strategies of the major players COVID-19 analysis and recovery route PESTEL and SWOT analysis besides other analysis

The report has been conceived and presented in an attempt to decode notable business decisions and trends based on which a thorough evaluation spectrum has been constructed to encourage growth oriented business discretion amongst budding market participants as well as established vendors willing to ensure hassle-free growth stride despite challenges and rising competition.

About Us :

We are a team of highly professional researchers dedicated to unravel ongoing market developments. We are recognized as best in industry one stop store, offering intensively researched market-oriented information with superlative standards of impartiality and authenticity in order to rightfully influence favorable business decisions across a range of verticals. We are highly dependent on our information scavenging abilities and extremely reliant on our intuitive capabilities that lead towards novel opportunity mapping and result in profitable business models and high revenue structures.

Contact Us :

Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

More here:
Global Cryonics Technology Market 2025 Current as Well as the Future Challenges: Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR - The Think...

Black Cumin Seed Oil (COVID-19 Version) Market 2020 Overview:

Reports Monitor has recently added a new report to its vast depository titled Global Black Cumin Seed Oil (COVID-19 Version) Market 2020. The report studies vital factors about theGlobal Black Cumin Seed Oil (COVID-19 Version) Marketthat are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and many more crucial aspects related to theGlobal Black Cumin Seed Oil (COVID-19 Version) Market.

Important factors like strategic developments, government regulations, market analysis, end users, target audience, distribution network, branding, product portfolio, market share, threats and barriers, growth drivers, latest trends in the industry are also mentioned.

TheTop Leading playersoperating in the market to Covered in this Report:Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils GmbH, Kerfoot Group, Earthoil Plantations, Life Extension, Nuverus, Omega Pharma, BioPraep& More.

Get PDFSample Reportof Black Cumin Seed Oil (COVID-19 Version) Market 2020, Click Here @https://www.reportsmonitor.com/request_sample/1044487

TheBlack Cumin Seed Oil (COVID-19 Version) Marketreport is segmented in the following categories:

Segmentation by product type :Food Grade, Cosmetic Grade

Segmentation by Application :Soap, Health Food, Personal Care Products (Massage Oils, Skin Care Products)

Following regions are highlighted in this report:

Understand the influence of COVID-19 on the Black Cumin Seed Oil (COVID-19 Version) Market with our analysts monitoring the situation across the globe.Get here sample analysis

The report on Global Black Cumin Seed Oil (COVID-19 Version) Market provides detailed segmentation by type, applications and regions. Each segment provides information about the production and manufacturing during the forecast period of 2015-2026. The application segment highlights the applications and operational processes of the industry. Understanding these segments will help identify the importance of the various factors aiding to the market growth.

The market research report on the Global Black Cumin Seed Oil (COVID-19 Version) market has been carefully curated after studying and observing various factors that determine the growth such as environmental, economic, social, technological and political status of the regions mentioned. Thorough analysis of the data regarding revenue, production, and manufacturers gives out a clear picture of the global scenario of the Black Cumin Seed Oil (COVID-19 Version) market. The data will also help key players and new entrants understand the potential of investments in the Global Black Cumin Seed Oil (COVID-19 Version) Market.

Avail discount while purchasing this report, Click [emailprotected]https://www.reportsmonitor.com/check_discount/1044487

Key features of this report are:

For More Details On this Report:https://www.reportsmonitor.com/report/1044487/Black-Cumin-Seed-Oil-Market

Contact UsJay MatthewsDirect: +1 513 549 5911 (U.S.)+44 203 318 2846 (U.K.)Email:[emailprotected]

Continued here:
Black Cumin Seed Oil (COVID-19 Version) Market Insights, Forecast to 2025 | Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils...

Q3 2020 Energy Recovery Inc Earnings Call San Leandro Oct 30, 2020 (Thomson StreetEvents) -- Edited Transcript of Energy Recovery Inc earnings conference call or presentation Thursday, October 29, 2020 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Bob Mao * James Siccardi Energy Recovery, Inc. - VP of IR * Joshua Ballard Energy Recovery, Inc. - CFO ================================================================================ Conference Call Participants ================================================================================ * Pavel Molchanov * Ryan James Pfingst B. Riley Securities, Inc., Research Division - Associate ================================================================================ Presentation -------------------------------------------------------------------------------- Operator [1] -------------------------------------------------------------------------------- Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the Energy Recovery Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, James Siccardi, Vice President of Investor Relations for Energy Recovery. Thank you, you may begin. -------------------------------------------------------------------------------- James Siccardi, Energy Recovery, Inc. - VP of IR [2] -------------------------------------------------------------------------------- Good afternoon everyone, and welcome to Energy Recovery's 2020 third quarter earnings conference call. My name is Jim Siccardi, Vice President of Investor Relations at Energy Recovery. I'm here today with our Chairman, President and Chief Executive Officer, Bob Mao; and our Chief Financial Officer, Joshua Ballard. During today's call, we may make projections and other forward-looking statements under The Safe Harbor provisions contained in the Private Securities Litigation Reform Act of 1995 regarding future events or the future financial performance of the Company. These statements may discuss our business, economic and market outlook, the Company's ability to commercialize VorTeq, growth expectations, new products and their performance, cost, structure and business strategy. Forward-looking statements are based on information currently available to us and on management's beliefs, assumptions, estimates or projections. Forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors. We refer you to documents the Company files from time to time with the SEC, specifically the Company's Form 10-K and Form 10-Q. These documents identify important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements. All statements made during this call are made only as of today, October 29, 2020, and the Company expressly disclaims any intent or obligations to update any forward-looking statements made during this call to reflect subsequent events or circumstances, unless otherwise required by law. At this point, I would like to turn the call over to our Chairman, President and Chief Executive Officer, Bob Mao. Bob, the floor is yours. -------------------------------------------------------------------------------- Bob Mao, [3] -------------------------------------------------------------------------------- Thank you, Jim. And thank you everyone for joining us today. I want to start today's call as I did last quarter, with sincere hope that everyone listening and your families are safe and healthy. Once again, I am happy to report that the Energy Recovery team and our business remain healthy and strong. Energy Recovery is evolving well into a COVID inspired new normal, where we continue to steadily achieve growth those in our base business as well as in our new business initiatives. The disciplined finance financial and time bounded approach to our new initiatives as recorded in our last call is being strictly executed, which should translate to a greater bottom-line results and increase returns for our investors. Following the format of my previous earnings call report, I will provide you updates to our Water business and VorTeq development in our Oil & Gas business. In addition, in our last earnings call, we committed to provide more details on our intubation effort for the PX technology platform, which was started at the end of the first quarter of this year. Today, we are happy to report our one of the efforts ZLD, Zero Liquid Discharge, which has just graduated into commercialization with receipt of the first purchase order. Let's begin with our water business, which continues to be healthy and strong, riding on incredibly strong global desalination grows even amidst the COVID pandemic. This third quarter was ERII's biggest water revenue generating quarter, eclipsing last year higher quarter record by 26%. At this time, we feel competent increasing our previously projected 20% to 25% of water's revenue growth for fiscal year 2020, up to 25%. We also feel confident in increasing our 2021 growth outlook to 10% from the flat to 5% gross we communicated last quarter. Finally, adjusting desalination industry trends allows us to optimistically anticipate water revenue growth in 2022 similar to what we are achieving in 2020. The strong global seawater reverse osmosis desalination growth trend is anchored in equivalent need to provide access to clean water in many parts of the world. In addition to the basic need, three other trends are helping to grow in seawater reverse osmosis. First, the technological shifts, from inefficient thermal desalination plants for reverse osmosis is becoming the growing portion of our pipeline. Second, acceptance of private financing into desalination construction in places like Saudi Arabia, Dubai, Egypt and India is increasingly decoupling desalination projects to national fiscal budgets, which you may be susceptible to oil price increase and COVID-19. And finally, geopolitical shifts are creating an urgent strategically move for desalination in countries like Egypt, where the construction of Nile river dam in Ethiopia, to recognize Egypt's water independence. In addition to our fundamentally strong baseline seawater reverse osmosis outlook, our first incubation initiative Zero Liquid Discharge or ZLD is focused on our water business specifically with wastewater industry. In fact, we are excited to announce that we received our first commercial purchase order to our new water wastewater product from a customer in India just this last week, which is really encouraging. A global regulatory push is currently being led by China and India to implement more environmentally friendly practices in industrial wastewater treatment. Those countries are struggling less maintaining clean water sources and they are seeking to maximize the recovery of clean water and minimize the impact of wastewater disposal polluting theirs water wastes. ZLD allows for this by fully removing the harmful industrial waste from the water and reintroducing or recycling only clean water. The ZLD market is in its nascent stages. It is fragmented market and the multiple competing technologies, none of which has emerged as a dominant technology. Much like the desalination market, we believe our reverse osmosis is the upcoming solution. However, unlike desalination the pressures needed to achieve zero or minimum liquid discharge are nearly 2,000 psi or roughly double that our seawater desalination. To address this, we are using our PX technology platform to build our high pressure PX application, which we call the Ultra PX. We believe our technology has the potential to become the dominant solution in ZLD wastewater just like our legendary PX has dominated the seawater reverse osmosis market. Our preliminary ZLD market research identified existing wastewater applications of our Ultra PX. There is a potential total addressable market in China as high as $100 million, which would not include further annual growth as the market expense. We see a similar opportunity in India, where we recently received our first purchase order, and we believe that markets globally will move further toward those new and minimal discharged technology overtime as clean water becomes a more critical resource. Nowadays, it has achieved commercialization, ZLD will move out of incubation and into our water business unit. We're proud of our R&D and commercial teams and their ability to commercialize our new Ultra PX with the several months' initial incubation well below our three years project movement. ZLD should achieve and returns on investment far exceed 20% and we anticipate ultimately achieving margins at levels comparable to our base water business. Finally, we anticipate positive operating cash flow around the asset with our first purchase orders in hand. We're truly confident in the potential of our water business, as we look forward. Our business, our baseline seawater desalination business continues to enjoy a superior upswing. There's no end in sight over the next few years and we're excited about the potential of our new wastewater business efforts. We look forward to update you on both in the future. Next, we turn to our Oil & Gas business and VorTeq where I continue to view the progress we made with great pride. We have developed our production model 1.0, which was utilized during our previously reported few simulation frac with Liberty oil fuel services. However, the three hurdles we outline must to be clear before we commercialize. One, successfully complete 2 to 3 live fracs. Two, validate our customer value proposition. And three, maximize the amount of sand that can be pushed through the cartridges before repair or replacement. As I said beginning of live frac and by extension our value proposition, we are aggressively seeking to get out in live frac before year end as live frac verification is critical to establishing the VorTeq value proposition for our customers and to verify our VorTeq cartridge service spec. In addition to our ongoing dialogue with Liberty, we have taken calls from and hosted indicators for additional oilfield service companies interested in the potential use of VorTeq. We are pleased with the response companies are giving us and the willingness which they have introduced VorTeq to their own customers. We remain confident in our ability to achieve the live well requirements as outlined last quarter and quantifying our value proposition. As soon as we have achieved our first live well, we will let you know. With regard to the final hurdle, we're making solid progress in cartridge life extension and manufacturing insurance. We believe we identified a solution to achieve our cartridge life or as a minimum, a solution that will give us a material step forward to this end goal and we will be testing the solution as we end the year. We're continuing to remind ourselves the new to commercialize VorTeq by midyear 2021 or I'll stopping this. Our committed timeline has not changed. Next, we report on incubation. I discussed earlier our ZLD initiative, the first incubation efforts to graduate to an exciting business unit. In addition to the ZLD market, there are a multitude of potential applications for our ultra-high pressure PX in a variety of industries within and outside of water. We see significant future potential for our ultra-high pressures PX technology and believe it could become a significant percentage of our revenue in the coming years. We're also making progress on the second PX incubation initiatives targeted at a very large growth of industry currently undergoing regulatory driven transformation. While this product has the potential of being transformative in much the same manner, the PX transformed the desalination industry, we are at the technology feasibility stage and so we'll forego detail discussion at this time. We expect to report on the progress of incubation efforts when we speak to you again in March, at which time, we will have either prove out technically feasibility or seek investment. Finally, we mentioned last quarter that we are working on a project that will expand the aperture of our PX technology platform, thereby creating new PX applications in new industries. This project is a zero mixing PX. Zero mixing simply means that there is no commingling of fluids as columns of liquid transfer their pressures within the PX. Such mixing dose occur in our current applications in desalination and in oil and gas, but mixing however slight can exclude the PX from the applied in many applications such as gas processing or chemical among others where our technology could potentially help reduce energy consumption and thereby cost new existing systems. We have already proven the technical feasibility of this extension of our technology and we are now working on longer life and reliability. As we begin to apply this technology to new applications, we will update you on our progress and the potential of these new markets. With that, let's turn to ESG. As you know, we released our inaugural ESG report in September. While our business has always been aligned with sustainability issues such as addressing global water scarcity and improve access to affordable and clean energy. Our ESG report reflects our commitment to become more sustainable and resilient business. The initial guide to build our ESG program will base on our business growth as well as inputs from our key stakeholders. The pursuit of more efficient, sustainable customers' solutions has been the core of our DNA, since our founding more than 20 years ago. We're proud of the impact that our technology has been making desalination more efficient and sustainable particularly as our growth comes from growing water scarcity. Our new ventures will continue to focus our energy efficiency and endowment. As we use own pressure exchange technology to drive new growth opportunities, we desire to do so while providing new efficient and sustainable solutions to industrial needs. This is an exciting time at Energy Recovery. Our water team is focused on maintaining the momentum of our desalination business as well as expanding our reach with launch of the new ZLD product. Our Oil & Gas team is focused on finding finance and commercializing VorTeq. And finally, our incubation efforts are focused on achieving technical verification on one product that could prove transformative and another that could further expand the aperture of our PX phase platform. We're transitioning Energy Recovery into a growth company on the basis of our very versatile pressure exchanger. We are giving you insights to this transition by reporting our progress, our wins and our failures. We are investing our hard earned cash and you should know how and why we are investing it. We will continue to tell you what to expect, give you updates on our progress, and provide details on the outcomes. If we fail, you will know why. But when we succeed, you should not be surprised. In short, you will see every punch we land and every step we take, and we do not plan to take hand fist. With that, I hand other over to Joshua. -------------------------------------------------------------------------------- Joshua Ballard, Energy Recovery, Inc. - CFO [4] -------------------------------------------------------------------------------- Thank you, Bob. As you saw last quarter, each channel in the water business continues to experience different dynamics. Mega-projects remain dominant, growing 70% year-on-year in the quarter and an impressive 48% year-to-date. As expected both the OEM and aftermarket channels remain weak as compared to 2019, falling 22% and 40% respectively in the quarter from a year ago. Based on Bob's affirmation of at least 25% growth in our Water business this year, you should expect a very strong fourth quarter. I've mentioned in the past calls that it's hard to pinpoint quarterly trends in our business. In both 2018 and '19, we experienced the drop off in sales in the fourth quarter. However, this year, our fourth quarter sales should be comparable to that of the third quarter. As we looked at '21, and '22, we do expect to see our OEM and aftermarket channels recover; however, the extent of that recovery will largely depend on the global effects of COVID over this winter and next spring. While some industries will remain weak within these channels regardless, most notably travel and hospitality. At this time, we believe pent up demand and other industries may help return the OEM and aftermarket channels to more normalized levels, which is leaning toward increased confidence in projections for next year. I should also note that revenue from our new ZLD market is not yet included in these projections, as we build our pipeline and grow more comfortable, will provide more clarity. That being said, it's probably fair to assume that our initial revenue will be in the single digit millions the first couple of years, with considerably more growth in the future. Also note that these projects will be of a different nature than the larger Mega-project desalination plant driving our water growth today. A typical ZLD project will be in the range of $50,000 to $150,000 in revenue, with our potentially a much larger number of these projects than we've seen in desalination. For example, if we assume $100 billion market in China, as Bob outlined, this will imply roughly 100 projects, whereas in desalination it could be as low as 10. Our product gross margin decreased by 360 basis points as compared to Q3 2019 which showed a healthy 550 basis point increase from our low mark in the second quarter of this year and somewhat exceeded our expectations this quarter. Our margin strengthening over last quarter is largely due to our return to normal production levels at the end of Q2. While we did have a small effect from COVID due to delay in the commissioning of our new ceramics plant in Tracy, California, that effect was muted compared to prior quarters. We are pleased with how well our manufacturing team is operating within the restrictions of COVID and we continue to work under strict protocols to ensure the safety of our employees as well as the continuity of our business. In addition, our decreased OEM sales led to lower than expected sales of turbochargers and pumps, which proved accretive to margins as these products are less profitable than our PX sales in this channel. Last year, we mentioned some margin pressure owning the low ASPs as a result of bigger order sizes as we serve ever larger desalination process. We expect the trend to continue in Q4 and around the fiscal year with roughly 68% to 69% gross margin despite a reduced effect from COVID. As we look to 2021, the fundamentals of our gross margin will remain largely the same, excluding the potential of any temporary COVID-19 related effects. At this time, we don't expect to see a shift in our water business outside of this 68% to 70% range. Let's now turn to our operating expenditures where we have reported a decrease of 9% compared to Q3 2019. While our OpEx is somewhat lower than planned today due to COVID, the real story is an R&D where you will see a 23% decrease compared to Q3 last year and a similar decrease as compared to the first half of 2020. While our R&D expense may increase somewhat in Q4, we expected to remain roughly 15% to 20% lower than the first half of 2020. If there is a single thing at bottom I want you to hear, it is that of discipline, discipline in our R&D efforts as well as our operations and by extension, our expenses. For example, this year we terminated some projects altogether that were not achieved our commercial KPIs in expenses from these projects. And as we look at our OpEx going forward, while we expect OpEx to grow, you're focused on reducing our spend as a percentage of revenue over the next 2 to 3 years to a more normalized level as related to our peers in the market. Over the past decade, we have reported annual OpEx higher than 60% to 65% of revenue every year. It would have been in a similar range this year and after the second quarter termination of this Schlumberger contract and subsequent GAAP recognition of the remaining license and development revenue. We are targeting our OpEx to drop to a range of 35% to 40% of revenue by 2022, subsequently to reduce it to the low 30s, which will be more in line with our peers in the market. Sustaining of OpEx will be done in two ways. First, we will be capping our R&D as a percent of revenue in our baseline budget. Our R&D expenses averaged over 20% of revenue in the past few years due to our elevated spend on the VorTeq. In 2021, we'll be targeting a range closer to 15% to 20%, with the goal lowering it further in 2022 towards a 10% to 15% range. Keep in mind that this percentage will be decreasing despite the fact that we are guiding total revenues lower next year due to this year's increase in revenue from the termination of the Schlumberger contract. You can expect a clear reduction in R&D by the second half of next year, as we reduced spend on the VorTeq and wind down those R&D activities. In addition, based on R&D spend on our incubation projects is expected to remain in the single digit millions a far cry from the levels that we saw with the VorTeq. Second, we will continue to leverage our existing infrastructure, which will slow G&A growth in the coming years. We have invested significantly in the new systems past 18 months to better modernize our operations, to leverage our back office as we grow and we should see the fruits of this labor as we expect G&A spending growth to continue to lag that revenue. This year G&A spend is somewhat lower than plan due to COVID-19. Next year, we expect more normalized G&A spend and growth will generally occur from inflation and a reversion to the norm rather than increasing resources. I expect total G&A to grow more than 10% in 2021 and further decrease in growth on subsequent years as like R&D we aim to reduce G&A as a percent of revenue to the mid to high teens over the medium to long term. Sales and marketing spend is expected to stay roughly where it is today, around 10% to 12% of revenue. Lastly, as we concern OpEx, please keep in mind that our current levels spend is soon success with the VorTeq. If the VorTeq does not commercialize in 2021, our overall OpEx spend would decline considerably as we reduce activities in our Oil & Gas business unit and cease R&D. If modeling you keep similar levels of OpEx, you should then assume revenue from the commercialization of VorTeq. If we commercialized the VorTeq, we expect up to a 40% to 50% reduction in Oil & Gas OpEx spend overall, with about half of that reduction due to shifting spend in the cost of goods sold once we begin to generate revenue and the other half to decreased R&D. Also, this will result in an overall reduction in total R&D spend of at least 20% to 25% next year. Total reductions will depend on how quickly we commercialize or cease operations. Finally, a few words on our cash and investments position which ended at $160 million for the quarter. We continue to see no effect on cash from the global economic uncertainty. In fact, our accounts receivable is the cleanest it has ever been, which is reflective of the strong position the desalination industry finds itself in despite the strange times. For now we continue to shift our corporate bond portfolio into cash and securities mature. As the future becomes more certain, we'll revisit our longer term plans. CapEx investments look to finish the year in the middle lower end of the $8 million to $10 million I guided this time last year. Our baseline CapEx for 2021 is planned at $5 million to $7 million. Now this baseline excludes any CapEx related to potential commercialization of the VorTeq, which will become clear, if and when we commercialize and we'll provide more clarity at that time. With that, let's move to the question-and-answer portion of our call. Thank you. ================================================================================ Questions and Answers -------------------------------------------------------------------------------- Operator [1] -------------------------------------------------------------------------------- Thank you. At this time, we will be conducting a question-and-answer session. (Operator Instructions) Our first question is from Pavel Molchanov with Raymond James. -------------------------------------------------------------------------------- Pavel Molchanov, [2] -------------------------------------------------------------------------------- I want to just review the guidance targets that you gave, make sure we all heard them right. Following 25% water revenue growth this year, it should slow to 10% growth next year, but then reaccelerate to 25% in '22. Is that correct? -------------------------------------------------------------------------------- Bob Mao, [3] -------------------------------------------------------------------------------- Correct. Yes, that is correct. -------------------------------------------------------------------------------- Pavel Molchanov, [4] -------------------------------------------------------------------------------- So what gives you the confidence that '22 will -- that will see the acceleration in the growth rate? Is it specific projects, specific geographies, specific customers? -------------------------------------------------------------------------------- Bob Mao, [5] -------------------------------------------------------------------------------- Actually, all of the above specific projects, specific geographies, and in fact, we already have some backlog going into 2022. So, it's not depending on macro market trends only, it is underground actually project by project, customer by customer. -------------------------------------------------------------------------------- Pavel Molchanov, [6] -------------------------------------------------------------------------------- And does it include retrofits of legacy plants? Or is it or are you only looking at greenfield new builds? -------------------------------------------------------------------------------- Bob Mao, [7] -------------------------------------------------------------------------------- Both. -------------------------------------------------------------------------------- Pavel Molchanov, [8] -------------------------------------------------------------------------------- My final question was about your comment about an industry that is being transformed by government regulation. And I'm sorry, if this is a silly question, but are you referring to the Oil & Gas industry or something else? -------------------------------------------------------------------------------- Bob Mao, [9] -------------------------------------------------------------------------------- We will clarify that next call as we are in the technical feasibility phase. -------------------------------------------------------------------------------- Operator [10] -------------------------------------------------------------------------------- Our next question is from Ryan Pfingst with B. Riley Securities. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [11] -------------------------------------------------------------------------------- In terms of your inventory of VorTeq equipment for the new single cartridge skin design, if the opportunity presented itself, could you simultaneously execute one well with Liberty and another with a different pressure pumper? If not, are you prioritizing the first attempted well with Liberty above all other options? Or if another interested party wanted to conduct the live well test before Liberty customers ready, would you move forward with that opportunity? -------------------------------------------------------------------------------- Bob Mao, [12] -------------------------------------------------------------------------------- We have enough inventories to those. So that pleasant opportunity always. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [13] -------------------------------------------------------------------------------- Okay. That's helpful. And then for hurdle numbers three on the path to commercialization, the buying of frac sand that the cartridge can process before needs to be repaired or replaced. How far along are you now towards your target? I know that by year-end, you aim to be at 50% with clear visibility, on raising a hundred percent. Could you give some insight on maybe what percentage you're at now or where you exited the third quarter? -------------------------------------------------------------------------------- Bob Mao, [14] -------------------------------------------------------------------------------- We are on track to reach those targets. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [15] -------------------------------------------------------------------------------- Okay. So on track for 100% visibility by your end. -------------------------------------------------------------------------------- Bob Mao, [16] -------------------------------------------------------------------------------- Yes. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [17] -------------------------------------------------------------------------------- Great. And then turning to the new PX derivative product developments, could you give some other examples of potential end users that you're investigating now? -------------------------------------------------------------------------------- Bob Mao, [18] -------------------------------------------------------------------------------- We shared particularly with zero mixing and that will open up additional end user into chemicals industry where no mixing is allowed at all. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [19] -------------------------------------------------------------------------------- All right. Thank you. And then maybe just one last one for Josh, could you please provide the third quarter breakdown for Water revenue by segments? -------------------------------------------------------------------------------- Joshua Ballard, Energy Recovery, Inc. - CFO [20] -------------------------------------------------------------------------------- Sure. It's 76% for the Mega-Projects, 15% for OEM and about 10% for aftermarket. -------------------------------------------------------------------------------- Operator [21] -------------------------------------------------------------------------------- (Operator Instructions) Our next question is from Ken Hirschberg, Private Investor. -------------------------------------------------------------------------------- Unidentified Analyst, [22] -------------------------------------------------------------------------------- Congratulations on the excellent quarter and all the progress you're making. Could you please give us an update on the commercialization of the IsoGen and IsoBoost? Thank you. -------------------------------------------------------------------------------- Bob Mao, [23] -------------------------------------------------------------------------------- On that one, we are in discussion with potential customers to deploy our standard product. And of course, our first project is fully in operation and the very happily accepted by our customers. So, what we look for here is for a standard product applicable to a larger base of customers rather doing individual almost custom-made projects. So, we're making progress. We expect to report more at the next earning call. -------------------------------------------------------------------------------- Unidentified Analyst, [24] -------------------------------------------------------------------------------- Is it for IsoGen and IsoBoost? -------------------------------------------------------------------------------- Bob Mao, [25] -------------------------------------------------------------------------------- Yes, both IsoGen and IsoBoost. Did I answer your question? -------------------------------------------------------------------------------- Unidentified Analyst, [26] -------------------------------------------------------------------------------- Yes, you did. Thank you very much. I appreciate that. -------------------------------------------------------------------------------- Bob Mao, [27] -------------------------------------------------------------------------------- Thank you. -------------------------------------------------------------------------------- Operator [28] -------------------------------------------------------------------------------- Ladies and gentlemen, we have reached the end of the question-and-answer session. Now, I'd like to turn the call back to James Siccardi for closing remarks. -------------------------------------------------------------------------------- James Siccardi, Energy Recovery, Inc. - VP of IR [29] -------------------------------------------------------------------------------- I want to thank everyone for joining us today. For your convenience, we've decided for our prepared remarks up on our website, you can access when you chance to get in. Thank you very much for joining us and we look forward to speaking with you again in March. Please be safe. Thank you. -------------------------------------------------------------------------------- Operator [30] -------------------------------------------------------------------------------- This concludes today's conference. We thank you for your participation. You may disconnect your lines at this time. Goodbye.

Excerpt from:
Edited Transcript of ERII.OQ earnings conference call or presentation 29-Oct-20 9:00pm GMT - Yahoo Finance

ReportHive added most up-to-date research on Withania Somnifera Extract Market Growth Factors, Applications, Regional Analysis, Key Players And Forecasts By 2026 to its huge collection of research reports.

Withania Somnifera Extract Market includes Overview, classification, industry value, price, cost and gross profit. It also covers types, enterprises and applications. To start with, analytical view to complete information of Withania Somnifera Extract market. It offers market view by regions with countries, development in Withania Somnifera Extract industry, opportunity with challenges, sales strategies, growth strategies and revenue analysis to include price. Withania Somnifera Extract Market report helps to analyses competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Withania Somnifera Extract Market Sales 2020 Industry Trend and Forecast 2026.

Withania Somnifera Extract Market Leading Players: Life Extension, Taos Herb Company, General Nutrition Centers, Jarrow Formulas, Huge Mountain, Organic India, The Vitamin Shoppe, NOW Foods, Solgar, Solgar, Piping Rock, Swanson

Request for Sample Report (Including COVID19 Impact Analysis, full TOC, Tables and Figures) of Withania Somnifera Extract Market

Withania Somnifera Extract Market impact Factors Analysis:Technology Progress/Risk, Substitutes Threat, Economic/Political Environmental modification. Technology Progress in connected trade, shopper Needs/Customer Preference modification.

The top geographical regions studied in this research report include North America, Europe, Asia-Pacific, Middle East, and Africa, South America and the rest of the world. The growing Withania Somnifera Extract Market and its progressive impact on the global economy is featured in this study. The competitive analysis of major Withania Somnifera Extract Industry players, market size analysis, dynamics, as well as the qualitative and numerical assessment, is conducted. The insights offered in this study will determine the potential of Withania Somnifera Extract Industry on global, regional and country-level paving the way for futuristic growth and investment feasibility.

The report covers exhaustive analysis on:

Market Segments Market Dynamics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain in the Withania Somnifera Extract Market. The report Withania Somnifera Extract Market provide in-depth analysis of current market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on Withania Somnifera Extract Market segments and geographies.

This Withania Somnifera Extract Market report begins with a basic overview of the market. The analysis highlights the opportunity and Withania Somnifera Extract Market trends that are impacted the market. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Withania Somnifera Extract Market insight regarding the things which are driving and affecting the earnings of the market. The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Market Segmentation: By TypeCapsule, Liquid

Market Segmentation: By ApplicationHealth Products, Drug

Quantifiable data:

Market Data Breakdown by Key Geography, Type & Application / End-User By type (past and forecast) Withania Somnifera Extract Market: Specific Applications Sales and Growth Rates (Historical & Forecast) Withania Somnifera Extract Market revenue and growth rate by the market (history and forecast) Withania Somnifera Extract Market size and growth rate, application and type (past and forecast)

>>> To get Incredible Discounts on this Premium Report, Click Here @ https://www.reporthive.com/2537898/check_discount

Highlights of TOC:

Report Overview: It includes major players of the global Withania Somnifera Extract Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends: This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Withania Somnifera Extract Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Withania Somnifera Extract Market are discussed.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Withania Somnifera Extract Market by application, it gives a study on the consumption in the global Withania Somnifera Extract Market by application.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region: This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles: Almost all leading players of the global Withania Somnifera Extract Market are profiled in this section. The analysts have provided information about their recent developments in the global Withania Somnifera Extract Market, products, revenue, production, business, and company.

Market Forecast by Production: The production and production value forecasts included in this section are for the global Withania Somnifera Extract Market as well as for key regional markets.

Market Forecast by Consumption: The consumption and consumption value forecasts included in this section are for the global Withania Somnifera Extract Market as well as for key regional markets.

Value Chain and Sales Analysis: It deeply analyzes customers, distributors, sales channels, and value chain of the global Withania Somnifera Extract Market.

Key Findings: This section gives a quick look at important findings of the research study.

>>> Make an enquiry before buying this report @ https://www.reporthive.com/2537898/enquiry_before_purchase

Why Report Hive Research:

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc.

Contact Us:

Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: https://www.reporthive.comEmail: [emailprotected]Phone: +1 312-604-7084

Life Extension, Taos Herb Company, General Nutrition Centers, Jarrow Formulas, Huge Mountain, Organic India, The Vitamin Shoppe, NOW Foods, Solgar, Solgar, Piping Rock, Swanson, Withania Somnifera Extract, Withania Somnifera Extract Industry, Withania Somnifera Extract Market, Withania Somnifera Extract Market 2020, Withania Somnifera Extract Market analysis, Withania Somnifera Extract Market Analysis in Developed Countries, Withania Somnifera Extract Market by Application, Withania Somnifera Extract Market by Type, Withania Somnifera Extract Market comprehensive analysis, Withania Somnifera Extract Market comprehensive report, Withania Somnifera Extract Market Development, Withania Somnifera Extract Market Evolving Opportunities With Top Industry Experts, Withania Somnifera Extract Market forecast, Withania Somnifera Extract Market Forecast to 2025, Withania Somnifera Extract Market Forecast to 2026, Withania Somnifera Extract Market Forecast to 2027, Withania Somnifera Extract Market Future Innovation, Withania Somnifera Extract Market Future Trends, Withania Somnifera Extract Market Google News, Withania Somnifera Extract Market Growing Demand and Growth Opportunity, Withania Somnifera Extract market growth, Withania Somnifera Extract Market in Asia, Withania Somnifera Extract Market in Australia, Withania Somnifera Extract Market in Canada, Withania Somnifera Extract Market in Europe, Withania Somnifera Extract Market in France, Withania Somnifera Extract Market in Germany, Withania Somnifera Extract Market in Israel, Withania Somnifera Extract Market in Japan, Withania Somnifera Extract Market in Key Countries, Withania Somnifera Extract Market in Korea, Withania Somnifera Extract Market in United Kingdom, Withania Somnifera Extract Market in United States, Withania Somnifera Extract Market insights, Withania Somnifera Extract Market is Booming, Withania Somnifera Extract Market is Emerging Industry in Developing Countries, Withania Somnifera Extract Market Latest Report, Withania Somnifera Extract Market opportunities, Withania Somnifera Extract market report, Withania Somnifera Extract market research, Withania Somnifera Extract Market Research report, Withania Somnifera Extract Market research study, Withania Somnifera Extract Market Rising Trends, Withania Somnifera Extract Market Size in United States, Withania Somnifera Extract market strategy, Withania Somnifera Extract Market SWOT Analysis, Withania Somnifera Extract Market Updates

Read more from the original source:
Comprehensive Report on Withania Somnifera Extract Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and...

With the advancing electronics and semiconductors industry, the demand for cold plasma (CP) has been on the rise. While the demand for applications such as coating and finishing, surface treatment, adhesion, and etching, associated with printed circuit boards (PCBs) is soaring, the market for cold plasma is also expected to benefit from a slew of applications arising in other end use industries. Moreover, increasing applications in food safety will also push the market for cold plasma further, over the next few years. As depicted in a recent research report published by Persistence Market Research (PMR), the US$ 1.4 Bn global cold plasma market is presumed to observe stellar growth over an eight-year projection period. Between 2018 and 2026, the cold plasma market will possibly expand at a CAGR of 16.3%, as indicated by PMRs globalcold plasma marketreport.

The potential applications of cold plasma technology traverse a wide range, including the extension of product shelf-life and environmental sustainability. Such applications have been attracting the scientific community towards cold plasma research, over the years. The CP technique has already been proven to be an economic and environment-friendly technology in the textile industry. Textile companies are increasingly adopting cold plasma technique in an effort to deliver improved textile finishing.

Request For Report[emailprotected]https://www.persistencemarketresearch.com/samples/17053

Cold Plasma Technology Soon to Transform Wound Treatment Space

While cold plasma applications in sterilization and disinfection are currently accounting for maximum revenue in the cold plasma market, rapidly emerging applications in wound healing and adhesion will reportedly create lucrative opportunities for stakeholders.

Coldplasmatech GmbH, a German company, is looking forward to introduce a novel CP technology that could potentially revolutionize the wound care treatment platform, especially in emergency rooms in hospitals. The CP technology involves a patch of cold plasma made of silicone (as a part of the wound dressing), which can be used in treatment of chronic wound infections with the help of UV radiations and ions. This technology is presumed to provide a high-tech, efficient alternative to antibiotics, considering its ability to accelerate the wound healing process. If the trials based on the application of the cold plasma technology in faster wound healing deliver convincing and viable results, industry experts predict that the CP technology could become a widespread method for treatment of chronic wounds and infection, in near future.

Cold Plasma Technology to Win Preference over Conventional Processing Technologies

Among all end use industries generating demand for cold plasma, electronics and semiconductors are foreseen to reign supreme. Whereas, rising demand for cold plasma is expected to uplift the prospects for cold plasma in food processing and packaging, and plastics and polymers industries.

Advanced cold plasma technology is being widely used in the in-package decontamination of fresh foods. Shelf-life extension will also remain a key objective of fresh food industry participants, using cold plasma as a unit technology. With successful trials of the regulation of contaminants mediated by cold plasma, the applications of cold plasma in agriculture sector are expected to surge in near future. Additionally, research shows that it is possible to degrade the chemical residues of pesticides to relatively lesser toxic and safer structures, by using cold plasma. It also offers an excellent alternative to conventional fertilizers and pesticides.

As far as the processed and packaged food industry is concerned, cold plasma has been proven to hold immense potential as a safe and eco-friendly alternative to traditionally used chemical processes. Moreover, it is considered as a novel non-thermal technology for processing of foods, especially fruits and vegetables, and poultry and meat prominently attributed to the non-thermal nature, versatile design, and economic pricing of cold plasma. Research findings also confirm that cold plasma treatment poses no or minimal impact on a products chemical, physical, sensory, and nutritional attributes. However, it still remains to be seen whether cold plasma processing will completely replace the traditionally used processing technologies, as the research outcome is still in the pipeline and demands more extensive research in order to reach its potential.

Request Report[emailprotected]https://www.persistencemarketresearch.com/methodology/17053

Company Profiles

For in-depth competitive analysis, buy[emailprotected]https://www.persistencemarketresearch.com/checkout/17053

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA Canada Toll Free: 800-961-0353

Excerpt from:
The global Cold Plasma Market to go steady between 2018 and 2026 - The Think Curiouser

Have you noticed lately that your social skills are, well, not great? If you find yourself rambling non-stop whenever you have real, in-person interactions (finally!) oron the opposite side of the spectrumhaving no clue how to answer a basic how are you? it could be the result of all that alone time.

And while theyre super important, social distancing and self-isolation have taken a toll on more than just the ability to socialize. Licensed clinical psychologist Aimee Daramus, PsyD, says extreme hanger, sleepless nights, or unexplained pain and exhaustion are also signs that this new normal (well never say it again, we swear), is affecting your body.

According to Dr. Daramus, its normal to feel bad when something bad is happening around you. Feeling bad and not functioning at 100 percent are pretty reasonable right now, she addsso consider that professional permission to cut yourself a break.

The upside, though, is that you can help yourself feel less blah by integrating some supplementswith the purpose of supporting your specific ugh areainto your everyday.

Thats why after picking Dr. Daramuss brain about all the effects of self-isolation (keep on reading for those), we tapped Michael A. Smith, MD, director of education at Life Extension, to pinpoint the specific supplements that can help you out when those effects hit you extra hard.

In addition to being confined to your home (already a doozy), this year may have brought other hardships you didnt see coming, which can result in an overall feeling of uneasiness. People are experiencing multiple losses right nowfrom death to unemployment to milestones that they were looking forward to and traditions they didnt get to participate in, Dr. Daramus says.

While no supplement is the answer to anxiety or depression (and you should definitely talk to a doctor if thats a concern for you), Dr. Smith suggests Life Extension FLORASSIST Mood Improvewhich features specific strains of probiotics as the superstar ingredientsfor some overall emotional well-being support.

Probiotics are so much more than gut health, and its critical, he says. Your microbiome has connections throughout your body, and one of those is mood. As an example, your gut makes serotonin as much as your brain does. (And thats part of the brain-gut connection.)

Along with adding a probiotic to your daily mix, be sure to prioritize self care. Whether that means sticking to your workout routine, going for a long midday walk to clear your head, or even taking fifteen minutes to just unplug from your laptop and chilldedicate time to just being.

If youve noticed yourself feeling more irritable or ready to burst into tears every time you see a puppy, its probably not because Mercury is in retrograde (at least not just because of that).

Emotions are closer to the surface and we dont have all of our usual coping skills, so its easier to cry, lash out at someone, drink too much, eat too much, or overindulge in other ways, she says.

Since a lot of those problems can stem from stress, and unfortunately nothing (yet) exists that can just zap the stress out of your body, Dr. Smith recommends opting for Life Extension Enhanced Stress Relief on the days you wake up overly on-edge. It has L-Theanine (green tea) and lemon balm together, and these ingredients can produce a nice calming effect without knocking you out, he says. And who couldnt use some more calm?

All of these effects of self-isolation fold into one another, so if youre feeling stressed or sad, your sleep might be offand vice versa for when you dont get enough sleep.

To combat those restless nights when you cant shut your mind off, Dr. Smith says Life Extension Fast-Acting Liquid Melatonin is a good go-to.* Its perfect for that person who doesnt need it every night, but who has bad days every once in a while.

So, when you feel the hours of ceiling-staring coming, you can take a deep breath, shut off your devices, and rely on your sleepy time sidekick. Oh, and speaking of deep breathing, maybe the next time you meet up with a pal, take a deep breath and then start rambling.

Paid Content for Life Extension

Top photo: Kathrin Ziegler/Getty Images

*For occasional sleeplessness

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Original post:
3 Ways Social Distancing Could Be Affecting You That You Dont RealizeAnd the Supplements to Deal With It - Well+Good

By SKIP MENDLER

(Applause.) Thank you. Thank you very much. Please yes, thank you please, be seated. (Applause continues.) Thank you again. (Applause subsides.)

My dear friends and fellow mortals:

It is my distinct pleasure, as well as honor, to address this fifth gathering of the Mortal Americans Party, and to accept your nomination to be your candidate for Prime Speaker of the New American Democratic Republic. (Applause.)

In the Mortal Americans Party, we have, at last, I believe, found the one thing that ultimately unites us all. Our friends in the Transhumanist Life Extension Party and the Eternal Life Party may disagree, of course, and we look forward to our ongoing discussionsbut for now, we have come together here today on one basic fact:

Were all gonna die. (Applause.)

Liberals, conservatives, atheists and believers alikeall races, genders, variations, mutations and modificationswhatever our backgrounds, whatever our present circumstances, whatever our dreams for the future, we have learned that we must always keep that one inalterable fact somewhere in our minds and let it inform all that we do.

For too long, we tried to pretend that death didnt matter. We kept it in the closet. We tried to hold it at bay with vitamin supplements and dentures, Viagra and facelifts. We idolized youth and kept the elderly at a safe distance.

But the pandemics, and the years of upheaval they have caused, have changed all that.

There is no one way to cope with mortality, of course. Some of us are of the eat, drink and be merry philosophy. (Drunken cheers from the Hedonist Caucus.) Some of us take refuge in the comforts of spirituality. (Shouts of Amen! and Namaste!) Some of us embrace the dark aspects of fatalism. (Silence from the goths under the bleachers.) We respect and honor each others decisions, as we would have our own respected and honored. But I think we who have come here, at least, have agreed that it is important to do what we can, in the time that we have, where we are, with what we have been given. (Applause.)

We have learned that it is not just about us, but about those who preceded us in history, and those to come, who will take up our path in the future. We have learned both to take the long view and to live with gratitude in the moment. We have learned that short-term personal gain is unfulfilling when compared to helping our fellow mortals cope with the pains and challenges of life. We have learned that we cannot be uninvolved in the lives of others, however hard we might try. We have learned that while it is good to live independently and self-sufficiently as possible, there is no shame in asking for help. We have learned, painfully, that unbridled self-centeredness, the idea that I gotta get mine, and to hell with the rest of you, does not workneither for an individual nor a nation.

Most of all, we have learned that todaythis momentis ineffably precious. We must use it as best we canwhether it is to go vote, to help a neighbor, to take care of ourselvesbecause we do not know if we will be given another chance.

So let us move forward, my friends, towards the inevitable, with uplifted spirits. Give out of your heart, as our slogan goes, until your heart gives out.

Let me leave you with the words of Phil Ochs:

And I wont be laughing at the lies, when Im gone

And I cant question how, or when, or why, when Im gone

Cant live proud enough to die, when Im gone

So I guess Ill have to do it while Im here.

(Applause.)

Here is the original post:
Mortal politics - The River Reporter

Chicago, United States: Global Oral & Dental Probiotics Market Report 2021, Forecast to 2026, The report focuses on encompassing several factors such as global distribution, manufacturers, and various regions. The report has summed up industry analysis size, share, application, and statistics associated with the global Peptide Synthesis market. The report delivers an in-depth competitive landscape, Growth opportunities, market share coupled with product type and applications. The report also estimates comprehensive market revenue along with Growth patterns, and the overall volume of the market.

Crucial information and forecast statistics covered in the Oral & Dental Probiotics Market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

Key players covered in the report include:Now Foods, Hyperbiotics, Oragenics, Life Extension, Lallemand

>Request for Sample Report (Including COVID19 Impact Analysis, full TOC, Tables and Figures) of Oral & Dental Probiotics Market @ https://www.reporthive.com/request_sample/2545608

NOTE: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Oral & Dental Probiotics Market which would mention How the Covid-19 is affecting the Oral & Dental Probiotics Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Oral & Dental Probiotics Players to Combat Covid-19 Impact.

Valuable information covered in the Oral & Dental Probiotics Market report has been segregated into key segments and sub-segments.

By Service typePowderChewable tabletsOthersBy End useChildAdultApplication 3

Oral & Dental Probiotics Market: Competition Analysis

The Report Hive Research study presents a comprehensive analysis of global, regional, and country-level players active in the Oral & Dental Probiotics Market. Competitive information detailed in the Oral & Dental Probiotics Market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player.

Important Questions Answered in the Oral & Dental Probiotics Market Report

Key Offerings of the Report

>>>>Get Full Customize Report @ https://www.reporthive.com/request_customization/2545608

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the epicenter of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.Compared with the United States, Europes economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germanys GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.Thanks to the effective control and policy support of the new epidemic, Chinas economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Oral & Dental Probiotics market in this environment.

In terms of revenue, this research report indicated that the global Oral & Dental Probiotics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Oral & Dental Probiotics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The ????Now Foods aims at producing XX Oral & Dental Probiotics in 2020, with XX % production to take place in global market, ????Hyperbiotics accounts for a volume share of XX %.

Why Go For Report Hive Research?

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high Growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: : https://www.reporthive.com

Email: [emailprotected]

Read the original post:
Oral & Dental Probiotics Market (Impact Of Covid-19) Opportunities, Top Vendors, Industrial Analysis, Business Investment And Trends In Industry...

An innovative research study has been offered by Futuristic Reports, offering a comprehensive analysis of the Global Reishi Mushroom Extract Market where users can get an advantage from the comprehensive market research report with all the essential useful information. This is the newest report, covering the existing COVID-19 impact on the Reishi Mushroom Extract market. It has fetched along with numerous changes in market conditions. This segment also provides the Reishi Mushroom Extract scope of different applications and types that can potentially influence the future market. The comprehensive statistics are based on current trends and historical milestones.

This report also delivers an analysis of production volume about the global Reishi Mushroom Extract market and each type from 2020 to 2026. The Reishi Mushroom Extract report explicitly features the market share, company profiles, regional viewpoint, product portfolio, recent developments, newest strategic analysis, key players in the market, deals, circulation chain, manufacturing, production, and newest market entrants. The existing Reishi Mushroom Extract market players, brand value, popular products, demand and supply, and other significant factors identified with the market help players will better understand the market scenario.

Get Exclusive Sample Copy on Reishi Mushroom Extract Market at: https://www.futuristicreports.com/request-sample/92577

Impact of COVID-19 on Reishi Mushroom Extract Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Reishi Mushroom Extract Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international market. The epidemic has immediately interrupted the requirement and supply series. The Reishi Mushroom Extract report also assesses the economic effect on firms and economic demands. Futuristic Reports has accumulated advice from several delegates of this Reishi Mushroom Extract business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

Some of the key players operating in this market include:

( Vitacost, Swanson, Life Extension, Natures Answer, Natures Way, New Chapter, Solaray, Solgar, Source Naturals, Vital Nutrients, Bio-Botanica)

Based on Product Type, Reishi Mushroom Extract market report displays the production, profits, cost, and market segment and growth rate of each type, covers:

Powder Liquid

Based on end users/applications, the Reishi Mushroom Extract market report focuses on the status and viewpoint for major applications/end users, sales volume, market share, and growth rate for each application. This can be divided into:

Health Care Products Essential Oil Others

Grab Your Report at an Impressive Discount! Please click here: https://www.futuristicreports.com/check-discount/92577

The report offers a comprehensive assessment of the progression and other Reishi Mushroom Extract market features in significant regions, including South Korea, Taiwan, North America, Europe, Canada, Germany, France, Southeast Asia, Mexico, and Brazil, Pacific, and Latin America. U.S., U.K., Italy, Russia, China, Japan, etc.

Features the following key factors:

Some of the Key Questions Answered in this Report:

Inquire More About This Report @ https://www.futuristicreports.com/send-an-enquiry/92577

Our Other Reports:

Global Sewer Cameras Market Research Report

Global Manganese Powder Market Research Report

Global Nutritional Yeast Market Research Report

Global Mountaineering Packs Market Research Report

Futuristic Reports

Name: Mark RiveraTel: +1-408-520-9037Email: [emailprotected]

Read this article:
Reishi Mushroom Extract Market Global Trends, Share, Size, Growth, Opportunities, and Forecast, Covid-19 Impact by 2026 - The Think Curiouser

The future of the United Kingdoms nuclear deterrent depends, in part, on decisions being made right now in the U.S. Congress. At stake are Britains plans to build a replacement for its current nuclear warhead. According to the U.K. defense secretary and senior U.S. officials, the United Kingdoms program is reliant on the United States pursuing its own new warhead program of record, the W93. But the Donald Trump administrations Fiscal Year 2021 request for funds for the W93 was first nixed by House appropriators and then excluded from the stopgap continuing resolution. It is neither clear whether the W93 program will eventually make it into the budget proper, nor whether it would be taken up immediately by a potential incoming Joe Biden administration.

The United Kingdoms new warhead will be housed in the U.S. Navys proposed new Mk7 aeroshell, and is intended to be developed in parallel with the W93 warhead, sharing key design parameters and using some common non-nuclear components. In April, U.K. Defence Secretary Ben Wallace wrote to members of Congress on relevant committees, claiming that their support to the W93 program in this budget cycle is critical to the success of our replacement warhead program and to the long-term viability of the U.K.s nuclear deterrent. Senior Trump administration officials have also repeatedly told Congress that a failure to fund the W93 will prevent the United States from supporting the British program. The future of a nuclear deterrent that the United Kingdomcallsits ultimate insurance policy as a nation and a contribution to the ultimate guarantee of collective Euro-Atlantic security is being called into question.

Most media discussion of Wallaces letter focused on the propriety of the defense secretary lobbying Congress. But Wallaces letter was remarkable on grounds of substance, not just process. At face value, his letter made very serious claims, suggesting that the fate of the United Kingdom as a nuclear power is in the hands not of members of Parliament, but of congressional appropriators. These claims deserve close interrogation not least by Parliament, which has so far failed in its duty of scrutiny. British legislators should be asking why, exactly, a new warhead is needed; what the backup plan in case U.S. assistance is disrupted; what military and technical requirements are being set for the new warhead; whether the United Kingdoms fraying infrastructure can deliver what is asked of it; and how much this endeavor will cost. Buried in these questions are significant risks and long-term strategic choices for the United Kingdom, the future of its nuclear deterrent, and Anglo-American defense ties.

Dependent Deterrent

The United Kingdoms nuclear force is strongly dependent, in material and programmatic terms, on the United States. The Royal Navy deploys four nuclear-armed submarines equipped with the U.S.-built and maintained Trident II D-5 submarine-launched ballistic missile, drawing from a common missile pool at Kings Bay, Georgia. The essence of this cooperative relationship on delivery systems has been in place since the conclusion of the Polaris Sales Agreement in 1963, signed after Prime Minister Harold Macmillan persuaded President John F. Kennedy to sell the United Kingdom the Polaris submarine-launched ballistic missile. Bilateral cooperation on warhead-relevant matters, including the transfer to the United Kingdom of special nuclear material and non-nuclear weapon components, is authorized under the 1958 U.K.-U.S. Mutual Defense Agreement, which freed London from Washingtons postwar prohibition on nuclear cooperation under the 1946 McMahon Act.

The United Kingdom is currently working on a successor submarine, the Dreadnought class, which will replace the currently deployed Vanguard class in the 2030s, and which will share a common missile compartment with Americas own successor class, the Columbia. In 2006, Prime Minister Tony Blair secured from President George W. Bush an agreement that the United Kingdom would participate in a missile life extension program so that the Dreadnought class could continue to carry the Trident II D-5. In addition, London would be invited to participate in any program to replace or further life extend the D-5. A program is now underway to develop a successor missile once the D-5 leaves service in 2042, currently designated the D-5 Life Extension 2.

The basic parameters of the British warhead are thus set by the need for it to be certified for use with an American missile system and housed in an American aeroshell. The United Kingdoms current nuclear warhead, the Holbrook, is sometimes referred to as an Anglicized version of the U.S. W76. It is certainly a similar design, and is referred to as such by U.S. national laboratories, although the degree of similarity is not publicly known. Several non-nuclear components of the warhead are known to be procured from the United States, including the arming, fusing, and firing system; neutron initiator; and the gas transfer system. The United Kingdom has made some updates to the Holbrook while the United States has conducted a life extension of the W76, now designated the W76-1, including at least the incorporation of the Mk4a arming, fusing, and firing system. However, it has not been publicly disclosed whether the United Kingdom has conducted an equally extensive life extension program of its own.

There is little reason to believe that the United Kingdom wishes to depart significantly from this model when it comes to building the next warhead. The structural incentives to hew closely to U.S. plans are strong. Procurement of non-nuclear components from the United States is seen as an obvious cost-saving measure, and reliance on U.S. facilities and information-sharing gives Britain a hedge against technological risks in design and certification. An explicit goal of the United Kingdoms program to modernize its nuclear infrastructure has in recent years been to increase engagement with the United States to align capabilities and requirements for any future warhead decision.

Unless the United Kingdom wants to diverge significantly from the United States, then its new warhead program needs a parallel U.S. program against which to align. Enter the W93. The announcement of a new program of record was good news for the U.K. nuclear establishment, which had been in a holding pattern during several years of U.S. deliberations and interservice wrangling. But the United Kingdom fields only one warhead in its nuclear arsenal, and so has considerably less margin for error than the United States, which already has two warhead types delivered by submarine-launched ballistic missiles (the W76-1 and W88, plus a lower-yield W76-2 variant), as well as the redundancy of two alternative delivery vehicles (land-based intercontinental ballistic missiles and strategic bombers), each with their own warhead types. The United Kingdom also appears to be working toward a rather pressing deadline. According to official U.K. statements, a replacement warhead could be needed as early as the late 2030s, and it has previously been estimated to take 17 years from a procurement decision to the eventual production of the warhead.

This sense of urgency leaves Britain in an uncomfortable position, because many in Congress do not appear convinced that the United States truly needs the W93 program to start right away. Funding for the W93 program was not anticipated to be required for two more years, and the timing of the administrations request has provoked pushback from Democratic legislators. One possible theory is that Trump administration officials want the W93 on the books before a potential Biden administration enters office. Another more concrete explanation is that U.S. defense officials might not trust the National Nuclear Security Administration the semi-autonomous agency within the Department of Energy which manufactures the United States nuclear warheads to deliver the W93 on schedule, and would like a more generous margin of error. The National Nuclear Security Administration request is only for the first of seven phases of warhead development, and calls for the relatively modest sum of $53 million, alongside a Pentagon request for $32 million for the Navy Mk7 program. The latter request, unlike that of the National Nuclear Security Administration, was originally approved by House appropriators.

Even if a potential incoming Biden administration agreed with the requirement for a new warhead for its submarine-launched ballistic missiles, it might still choose to delay the program. This could be a symbolic gesture toward reducing emphasis on nuclear weapons, or a practical recognition both that National Nuclear Security Administration already has four life extension or modification programs to execute and a new sea-launched cruise missile warhead to produce, and that the U.S. nuclear modernization program is shaping up to be spectacularly expensive at a time of COVID-19 induced budget pressure. Even without a conscious decision to delay the program, it might still be pushed back if a Biden administration wished to consider the W93 in the context of a Nuclear Posture Review, which would take time to complete.

Unanswered Questions

The United Kingdom, in other words, is in quite a bind. The defense secretary has stated, in writing, that the viability of the British deterrent depends on a program which the U.S. Congress might be about to stymie. It could be the case that, if work on the Mk7 aeroshell can start even in the absence of National Nuclear Security Administration funding for the W93, the United Kingdom could begin work on its own program. But the longer that Britain proceeds without a parallel U.S. warhead program in place, the greater the risks it would be incurring. Vanishingly little is publicly known about the decision-making process which has led to this point, which makes the precise degree of risk facing the United Kingdom very difficult to judge.

Congress has now had four public hearings at which the W93 was discussed, including several references to the programs importance to the United Kingdom, and the administration has given briefings on the rationale behind the program. Yet in the United Kingdom, where the stakes are allegedly much higher, the sum total of the governments public output on the warhead is a vaguely written statement to Parliament, and confirmation that the warhead will use the Mk7 aeroshell. This leaves open several key questions.

Why Has the United Kingdom Decided to Build a New Warhead, Rather Than Seeking to Further Refurbish or to Remanufacture Holbrook?

The fact that the United Kingdom has decided to build a new warhead at all, rather than seeking to further prolong the life of the Holbrook, is something that needs justifying. Has the United Kingdom made an independent judgment that a replacement warhead is essential, or is this decision simply the combination of a U.S. decision to proceed with W93 and the United Kingdoms preference for alignment? Ever since the 2006 White Paper in which the decision to renew the ballistic missile submarine force was taken, the U.K. government has repeatedly told Parliament that at some point a decision on whether to build a new warhead would be need to be made. That decision has now been made, and Parliament and the public do not know why.

It is not clear that the United States sees a critical need to replace the W76-1, which has recently been life-extended, providing for additional decades of use. Some discussions of the W93s role suggest that it could exist in parallel with both the W76-1 and the W88 as one of Americas three submarine-launched ballistic missile warheads. Were the United States to decide that the W76-1 could be further life-extended, or remanufactured from scratch, the U.K. government has not yet provided any public reasoning why the same could not be done for the Holbrook. Such reasons can certainly be imagined: there might be materials used in the original U.K. design that have now aged, and cannot for technical, legal, or safety reasons be remanufactured other than at disproportionate cost. There is also a case to be made that further life-extending old warheads introduces a degree of risk of technical failure that is unacceptably high for a country that depends on a single design, and that changes in the security environment, such as developments in missile defenses, could set future military requirements that the current warhead cannot meet. These arguments, however, have not yet been publicly made by the U.K. government.

What Are the Critical U.S. Activities on Which the U.K. Replacement Warhead Will Depend in the Next Few Years, and What Is the United Kingdoms Backup Plan if These Activities Are Not Funded?

The U.K. government has emphasized the need for its warhead to be compatible with Americas Trident system. What this probably means in practice is that the United Kingdom needs to know key parameters of the Mk7 aeroshell which will define the size, shape, mass distribution, and other aspects of the British warhead which will fit inside it. Beyond that, in order for the United Kingdom to be able to cooperate closely with the United States on key scientific and engineering aspects of the warheads design, manufacturing, and certification, the United Kingdom will need to know U.S. intentions for various design choices. Until the United States starts work on the W93 program, the United Kingdom will either have to delay its own choices or make assumptions about likely U.S. decisions in order to begin necessary work. Either path could involve increased costs and technical risk.

Beyond a small delay, more serious disruption to the W93 program raises very challenging questions: would the United Kingdom pursue indigenous production of components that would otherwise have been procured from the United States, and if so, at what risk and cost? If the United Kingdom still wishes to remain aligned with the United States, are there alternatives to a replacement warhead based on the W93/Mk7? More broadly, Parliament might ask whether such close alignment to the United States is truly worth the accompanying loss of sovereignty. It is often assumed that the United Kingdom has simply no other option, and a more independent program would certainly involve taking a greater share of technical risk and would very likely incur greater financial costs. Nevertheless, close alignment with the United States has downsides as well as upsides, including greater vulnerability to disruption or delayed supply of materials, components, and expertise, and less discretion in setting military and other requirements for the warhead. This is a strategically important choice which has not yet been fully debated in public.

What Are the Likely Requirements for the W93, and How Do These Relate to the U.K. Program?

Assuming that the W93 program does go ahead, the first phases of its development will involve, among other things, the drafting of military characteristics and a stockpile-to-target sequence. Taken together, these will define the performance requirements and physical characteristics of the weapon, as well as the environments and threats it will be exposed to that must be taken into account in its design. This will require deciding, for example, what explosive yield the warhead will have, what defenses it must defeat including nuclear, hit-to-kill, and (potentially) directed energy weapons and what kind of hardening and countermeasures will be necessary. Choices will also be made regarding surety requirements, such as whether to use insensitive high explosives, which could mean a relative increase in mass and volume.

Requirements set in the United States during this process are likely to determine or strongly influence several characteristics of the British warhead. Embedded in those requirements are important implications for U.K. policy and strategy, and although London is likely to have a voice in U.S. discussions over such questions, it will not have a deciding vote. Briefings by U.S. officials suggest, for example, that the W93 is intended to be of higher yield than the W76-1. If the United Kingdom were to follow this path, the overall explosive yield of its operational stockpile could increase for the first time since it began deploying Trident in 1994. The emphasis placed by U.S. officials on the W93s flexibility implies variable yield, which would be somewhat consistent with the existing lower-yield warhead variant the U.K. reportedly deploys at present, but would leave the United Kingdom vulnerable to accusations that it was reinforcing a global trend toward the development of supposedly more usable nuclear options. Any potential improvement to the warheads ability to strike hard targets might also draw criticism from those opposed to enhancements in nuclear weapon capabilities, as was the case when the U.K. began introducing the Mk4a arming, fusing and firing system. Lastly, U.K. defense planners might be thinking about future deterrence requirements for countries other than Russia, the traditional driver of U.K. warhead needs. This might have an impact on the requirements for a new warhead, such as on the question of the new warheads weight, which helps determine the maximum range that missiles can reach. This is a potentially relevant factor when considering the risk that future developments in anti-submarine warfare might complicate U.K. operations.

Can the United Kingdom Successfully Execute a Warhead Replacement Program?

The state of the United Kingdoms nuclear weapons infrastructure suggests that the country will face significant challenges in producing its next warhead, even if cooperation with the United States runs entirely smoothly. By now, at least three key U.K. facilities should have been up and running: Pegasus (to handle enriched uranium components), Mensa (to assemble and disassemble warheads), and Hydrus (to conduct hydrodynamic tests). None is fully operational. Pegasus has been suspended after initial designs were judged too expensive and unwieldy, Mensa is now being built at least six years late and at more than twice the original cost, and Hydrus has been replaced by a joint U.K.-French hydrodynamic facility in France not scheduled to be fully operational for the United Kingdom at least until 2022.

More fundamentally, this will be the first warhead the United Kingdom has designed for some thirty years, and the first ever without explosive nuclear testing. It will also be designed just as the last generation of Atomic Weapons Establishment employees with firsthand experience designing new warheads are retiring. With civil nuclear projects also planned for the coming decades, the Atomic Weapons Establishment will be facing considerable workforce recruitment, training, and retention challenges.

How Much Will the United Kingdoms New Warhead Cost?

In the context of the COVID-19 crisis, the forecast hit to the U.K. economy caused by Brexit, and an ongoing strategic review, there is likely to be financial pressure on the warhead program even if it is shielded from immediate cuts. Yet the government is staying remarkably coy about the projected costs of the new warhead. The 2006 White Paper estimated the cost to be 2 to 3 billion pounds ($2.6 to $3.9 billion). This estimate was confirmed in government documents as late as 2013. Since then, however, no official estimate has been provided, although the 2013 Trident Alternatives Review, a government-published document though not a statement of policy estimated the cost of a new submarine-launched ballistic missile warhead to be 4 billion pounds in 2012 prices.

The Nuclear Warhead Capability Sustainment Program, under which much of the supporting infrastructure for building a new warhead was supposed to be built, has an overall budget of 21 billion pounds spread out from 2005 to 2025, and is subject to the scrutiny requirements applied to major projects. The government has said that the program to build the new warhead will also be subject to those requirements, but is not giving a specific cost estimate, citing national security concerns. Likewise, it has not said which parts of the Nuclear Warhead Capability Sustainment Program will be subsumed under the new warhead program. It is certainly tricky to separate the costs of the new warhead from the overall costs of having nuclear infrastructure capable of maintaining the existing warhead. And yet not only has the U.K. government done so in the past making it difficult to imagine national security grounds for withholding the information now the U.S. government has also provided estimates of how much the W93 might cost: $14.4 billion, according to the Nuclear Security Administrations last published assessment.

Take Back Control

The United Kingdoms replacement nuclear warhead program is a long-term, complex, and expensive endeavor. It deserves proper scrutiny. And while many of the technical details of the U.K. warhead must remain classified, the broad parameters of the decision the government has made and the risks the program faces are fair game for public debate. The British public learned of the decision to replace the Holbrook warhead not because the government decided to announce it, but because U.S. officials told Congress and reporters in February. In several respects, the transparency of the U.S. government, and the persistence of Congress in extracting answers, is throwing the opacity of the United Kingdoms nuclear warhead program into stark relief. It is time for Parliament to take back control.

Matthew Harries (@harries_matthew) is a senior research fellow at the Royal United Services Institute for Defence and Security Studies (RUSI). He previously worked on the staff of the U.K. House of Commons Foreign Affairs Committee. Prior to that, he was managing editor of Survival and a senior fellow at the International Institute for Strategic Studies (IISS). This article is drawn from a research project supported by the John D. and Catherine T. MacArthur Foundation.

Image: U.S. Navy (Photo by John Kowalski)

See the rest here:
Will America Help Britain Build a New Nuclear Warhead? - War on the Rocks

A comprehensive analysis of the market structure along with the forecast of the various segments & sub-segments of the market have been delivered through this Wellness Supplements Market document. The market is greatly transforming because of the moves of the key players and brands including developments, product launches, joint ventures, mergers and acquisitions that in turn changes the view of the global face of ABC industry. This market research report is a window to the industry which explains what market definition, classifications, applications, engagements and market trends are. The Wellness Supplements Market business report defines CAGR value fluctuation during the forecast period of 2020-2026 for the market.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-wellness-supplements-market&rp

This Wellness Supplements Market analysis report offers all-inclusive study about production capacity, consumption, import and export for all the major regions across the world. Furthermore, the statistical and numerical data such as facts and figures are represented very neatly in this report by using charts, tables or graphs. This market document also involves strategic profiling of the major players in the market, comprehensive analysis of their basic competencies, and thereby keeping competitive landscape of the market in front of the client. The global Wellness Supplements Market report covers all the market shares and approaches of the major competitors or the key players in the market.

Market Analysis and Insights: Global Wellness Supplements Market

Wellness supplements market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 386.29 billion by 2027 growing at a CAGR of 6.45% in the above-mentioned forecast period. The growing awareness towards healthy lifestyles among the people globally will help in driving the growth of the wellness supplements market.

The major players covered in thewellness supplements marketreport areLife Extension, OPTAVIA LLC, Beachbody LLC, Natures Sunshine Products, Inc, Organo Gold., Thrive Life, LLC, Phytoscience Trvo, Oriflame Cosmetics AG, Melaleuca Inc, Shaklee Corporation, Arbonne International, LLC., Forever Living.com, L.L.C, Juice Plus+, Herbalife International of America, Inc, and Isagenix Worldwide LLC, Nikken Inc., Wellness Resources, Inc., The Daily Wellness Company, Otsuka Holdings Co. Ltd, Glanbia plc, Nestle, Nuskin, USANA Health Sciences, Inc., among other domestic and global players.Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Get Full TOC, Tables and Figures of Market Report @https://www.databridgemarketresearch.com/toc/?dbmr=global-wellness-supplements-market&rp

Increasing ageing population, raising disposable income in developing countries and rising demands towards the healthy and cosmetic products will likely to accelerate the growth of the wellness supplements market in the forecast period of 2020-2027. On the other hand, gradual shift towards newer technologies and natural products and growth potential offered by emerging markets will further boost various opportunities that will lead to the growth of the wellness supplements market in the above mentioned forecast period.

Lack of traditional food categories, high cost of supplement food products, regulatory issues and increasing incidence of health issues will likely to hamper the growth of the wellness supplements market in the above mentioned forecast period.

This wellness supplements market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on wellness supplements market contact Data Bridge Market Research for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Wellness Supplements Market Scope and Market Size

Wellness supplements market is segmented on the basis of dietary supplements, functional food and beverage, nutricosmetics and free from food. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Wellness Supplements Market Country Level Analysis

Wellness supplements market is analysed and market size insights and trends are provided by country, dietary supplements, functional food and beverage, nutricosmetics and free from food as referenced above.

The countries covered in the wellness supplements market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the wellness supplements market due to growing cognizance and acceptance of wellness products and increasing focus towards healthy lifestyles while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to rising aging population and growing disposable income of the region.

The country section of the wellness supplements market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Wellness supplements market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for wellness supplements market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the wellness supplements market. The data is available for historic period 2010 to 2018.

Customization Available: Global Wellness Supplements Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-wellness-supplements-market&rp

About Data Bridge Market Research :

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail:Corporatesales@databridgemarketresearch.com

Here is the original post:
Wellness Supplements Market : Incredible Possibilities, Growth With Industry Study, Detailed Analysis 2020-2027 | Leading Players Life Extension,...

Newswise SAN ANTONIO, TEXAS (October 19, 2020) Texas Biomedical Research Institute (Texas Biomed) Professor Luis Martinez-Sobrido, Ph.D., recently released study findings, alongside colleagues at the University of Alabama at Birmingham and Aridis Pharmaceuticals, Inc. indicating that a human monoclonal antibody (hmAb) 1212C2 showed promise for further clinical development for preventative use or as a therapy for SARS-CoV-2, the virus that causes COVID-19. Earlier this year, the consortium of scientists isolated specific B cells from patients infected with SARS-CoV-2 and developed a panel of hmAbs that not only bind to SARS-CoV-2 infected cells, but also neutralize the ability of the virus to infect cells. The hmAb 1212C2 was subsequently licensed to Aridis Pharmaceuticals.

Taking the study a step further, the scientists have shown, as outlined in the study on BioRxiv, that delivering hmAb 1212C2 directly to the lung through inhalation using Aridis proprietary formulation and plasma half-life extension, or by injection showed significant reduction in viral load in the lungs.

Antibodies are proteins produced by the bodys immune system to fight off infections. Monoclonal antibodies are commercially or experimentally produced antibodies derived from the original antibody producing cell. Scientists worldwide have shown that the Receptor Binding Domain (RBD) region of SARS-CoV-2s Spike protein is a key target for any drug that aims to stop the virus from attaching to cells through the human angiotensin converting enzyme 2 (ACE2) protein. If the virus cant attach to the cell, it cant infect and propagate. The hmAbs were discovered by the labs of Dr. James Kobie and Dr. Mark Walter at the University of Alabama at Birmingham in collaboration with Dr. Martinez-Sobrido.

In both lab and animal experiments, hmAb 1212C2 produced a preventative and therapeutic effect against SARS-CoV-2. In hamster models, delivering formulated and plasma half-life extended hmAb 1212C2 through a nebulizer at low dosage produced a significant reduction of the virus and lessened disease progression in the lungs.

These are critical findings as we look to develop vaccines and therapies that are not only effective, but also efficiently manufactured and easily administered to patients, Dr. Martinez-Sobrido explained.

Nearly 40 million people globally have contracted COVID-19 with more than one million deaths, and the worldwide pandemic is not slowing down. Neutralizing antibodies developed either by natural infection or through vaccination, or administered as a therapeutic are critical to the overall protection of the human population.

Administering targeted human antibodies that bind tightly to SARS-CoV-2 is a promising approach to advance therapies. We must have more effective therapies to reduce the death rate from this ongoing pandemic. I am excited about the opportunity to advance hmAb 1212C2 with Aridis Pharmaceuticals, said Dr. Larry S. Schlesinger, President/CEO of Texas Biomed.

The cohort of scientists licensed hmAb 1212C2 to Aridis for further development as both a possible prophylactic for preventing COVID-19 and as a treatment for COVID-19, while also looking at opportunities to use this hmAb in combination with other hmAbs, or with other antiviral therapies.

Staff in Dr. Luis Martinez-Sobridos lab who contributed to this research include Jun-Gyu Park, Fatai Oladunni, Chengjin Ye and Kevin Chiem.

###

Texas Biomed is one of the worlds leading independent biomedical research institutions dedicated to eradicating infection and advancing health worldwide through innovative biomedical research. Texas Biomed partners with researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, hemorrhagic fever, tuberculosis and parasitic diseases responsible for malaria and schistosomiasis disease. The Institute has programs in host-pathogen interaction, disease intervention and prevention and population health to understand the links between infectious diseases and other diseases such as aging, cardiovascular disease, diabetes and obesity. For more information on Texas Biomed, go towww.TxBiomed.org.

Excerpt from:
Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against...